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Abstract
Clinical experience suggests that adults with dengue manifest a pattern of 
complications different from those observed in children, but direct comparisons 
among populations experiencing the same exposure have rarely been published. I 
conducted a large prospective descriptive study of dengue across all age-groups 
presenting to a single institution in an endemic country during a defined time-period. 
Vascular leakage was more severe in the paediatric patients and DSS developed 
much more frequently in this age-group. In contrast haemorrhagic manifestations 
and severe organ involvement were more common in adults. Similar to the 
established findings in children, typical coagulation abnormalities were apparent in 
the adults -  i.e. prolonged APTT with reduced fibrinogen levels but without 
evidence of true disseminated intravascular coagulation. However thrombocytopenia 
was significantly worse among the adults throughout the evolution of the disease, 
even after adjusting for the higher rate of secondary infections in this group, and 
platelet counts after recovery remained lower than in the children. Clinically severe 
liver involvement was seen only in adults and was infrequent but usually resulted in 
severe bleeding. Chronic hepatitis B co-infection was associated with modestly but 
significantly increased levels of alanine aminotransferase, but did not otherwise 
impact the clinical picture.
To investigate the mechanisms underlying the increase in APTT I carried out APTT 
Mixing Studies confirming that deficiency of coagulation factors is a major 
contributory factor. Since there is little evidence for procoagulant activation the most
likely mechanism for this would be leakage of coagulation proteins, many of which 
are of a similar size to albumin. An additional explanation for the increased APTT 
could be the presence of a circulating anticoagulant - I found very high levels of 
heparan sulfate (HS) in the dengue plasma, but was not able to show that the HS 
exerts an anticoagulant effect. I also used FACS analysis to demonstrate that 
circulating endothelial cells (CECs) are increased during dengue infections and that 
percentage CECs correlate with the severity of the coagulopathy and with bleeding. 
Parallel increases in both CECs and HS levels support the theory that disruption of 
the endothelial cell/glycocalyx complex occurs during dengue infections - i.e. CECs 
appear to be shed from the endothelial layer while HS may be shed from the surface 
glycocalyx. These disruptions likely affect the function of the complex and could 
contribute to the pathogenesis of the systemic vascular leak syndrome.
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Chapter 1 - Introduction
1.1 Dengue infection - the disease burden
Dengue infection is the most important arthropod-borne viral disease in tropical and 
sub-tropical countries, not only across Southeast and South Asia but also in Central 
and South America. Transmission is also seen in Africa, Australia and the Eastern 
Mediterranean (Figure 1.1) [ 1 ].
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Figure 1-1: Countries/areas at risk of dengue transmission, 2008. (Taken from  
World Health Organization (WHO) Guideline, 2009)
It is estimated that 2.5 billion people are at risk of the disease and annually there are 
around 50 millions symptomatic dengue cases worldwide. The disease has spread 
rapidly over the last several decades, with increasing numbers of cases reported, 
together with ongoing geographic expansion to new countries (Figure 1.2) [1]. The 
disease occurs mainly in urban areas but is now increasingly occurring in rural areas. 
Dengue disease has considerable social and economic burden for the population in 
endemic regions [2].
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Figure 1-2: Average annual number of dengue cases reported to WHO, and of 
countries reporting dengue, 1955 to 2007. (Taken from WHO Guideline, 2009)
1.2 Dengue -  the historical aspect
1.2.1 Dengue-like illness outbreaks
Dengue-like illness were firstly noted in China in 992 and then in the West Indies 
(the islands of the Caribbean) in 1600s but without detailed information o f the 
disease described. The first detailed description of the disease was made during the 
Philadelphia outbreak in 1780 by Benjamin Rush with the name “break-heart fever”. 
At the same time, the term “break-bone fever” was used in Spain to describe the 
outbreak. Dengue-like outbreaks were frequent in North America and tropical
• • • t i l  t hregions in Australia and Asia during the 18 and 19 centuries. The term “dengue”
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has been commonly used since the outbreak in Cuba in 1828. Later, after World War 
II when techniques for identifying the causative agent became available, the virus 
found to be responsible was called the dengue virus [3].
1.2.2 Dengue haemorrhagic fever epidemics
A dengue haemorrhagic fever (DHF)-like disease syndrome with shock and 
haemorrhage was described in Australia between 1897 and 1902, in Greece in 1928, 
and in Taiwan in 1931. However, the modern DHF pandemic of this more severe 
disease form started to emerge in The Philippines in 1954, in Thailand in 1956 and 
then subsequently in all countries across Southeast Asia. After that, dengue 
reemerged in Cuba with the first DHF epidemic in 1981 and since then it has spread 
widely in many countries across Central and South America [3].
1.3 Dengue virus
Dengue virus (DENV) comprises four antigenically distinct serotypes (DENV-1, 2, 
3, and 4) and belongs to the family Flaviviridae, genus Flavivirus. Based on genetic 
studies of sylvatic dengue strains, four dengue serotypes are thought to have evolved 
from a common ancestor in non-human primate populations and each entered the 
urban cycle independently around 500 -  1000 years ago [4]. The virus is a small 
single stranded, positive-sense RNA virus, containing about 11,000 nucleotides. The 
virus particles are spherical in shape and are approximately 50 nm in diameter, with 
a lipid envelope. The virus contain three structural proteins - the small basic capsid 
(C) protein around the genome of the virus and the envelope (E) and membrane (M)
4
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proteins on the envelope of the virus, and seven nonstructural (NS) proteins named 
NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 (Figure 1.3) [1,4].
NS4&
NS1 N53
NS2B NS4B
Figure 1-3: The dengue virus genome [4].
The single open reading frame encodes three structural proteins (the C, M  and E  
glycoproteins) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B and NS5).
Each dengue serotype has distinct genotypes, suggesting that DENV has large 
genetic variation. It is reported that “Asian” genotypes of Dengue 2 and Dengue 3 
are more virulent than “American” genotypes [1].
All four dengue serotypes are now circulating in all affected regions in Asia, Africa 
and America. This is different from the pattern seen 20 to 30 years ago, when 
serotypes 3 and 4 were not found in America and Africa [4].
1.4 Dengue vector
Aedes aegypti mosquitoes, which are the principle vector of dengue, transmit DENV 
from infected persons to other persons through their bites. These mosquitoes were 
firstly identified as the dengue vector in Brisbane in 1904 by Bancroft [5]. Because 
these mosquitoes need warm temperatures to survive, they are found in tropical and 
subtropical regions. High seasonal rainfall and high environmental temperature, the
5
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latter more important than the former, are the two main factors that are thought to 
have contributed to expansion of the Aedes aegypti mosquito population and 
consequently resulted in increased dengue transmission. Aedes aegypti lives indoors 
or around human dwellings and has limited flight range and dispersal. However, the 
mosquitoes and/or their eggs can be brought to other places a long distance away by 
transportation vehicles, or as a result of trade in suitable containers such as used 
vehicle tyres. Mosquitoes usually lay eggs on the walls of natural or artificial water 
containers, including household water storage containers, and vehicle tyres. Aedes 
aegypti mosquitoes have diurnal feeding, with two peaks -  one peak at midmorning 
and the other in the late afternoon [1,6]. The viruses drawn from infected persons 
enter the mosquito intestinal tract and undergo various essential life-cycle steps in 
the mosquito. After an extrinsic incubation period of approximately 10 days, the 
viruses pass to the salivary glands and can infect healthy persons when these persons 
are bitten by the mosquito [4].
Dengue virus can also be transmitted by other Aedes mosquitoes such as Aedes 
albopictus, Aedes polynesiensis. These mosquitoes have particular bionomics, 
behaviors and geographical distribution, which are thought also to have influenced 
the expansion of disease although to a lesser extent than Aedes aegypti [6].
1.5 The hosts -  epidemiological factors associated with infection and disease 
severity
The disease only affects humans although many genera of non-human primates 
develop viremia after they are infected with DENV through mosquito bites or during
Chapter 1 ~ Introduction
inoculation experiments, although they remain asymptomatic [3]. As discussed 
below some host factors can influence the risk of infection and disease severity.
1.5.1 Age
Age is one of the crucial factors influencing the epidemiology of disease. In the past, 
dengue predominantly affected children, particularly in the school age group. In 
addition infants under one year may experience symptomatic disease with high risk 
of severe dengue and death [7,8]. Possible reasons for this are discussed further 
under the section 1.10.1.
At the present time, although the main disease burden is still in children, increasing 
numbers of young adults are requiring hospitalization, often with significant 
associated morbidity and mortality [9,10]. One plausible explanation for this trend 
could be a reduction in the force of infection due to socioeconomic development 
and/or improved vector control such that fewer people are exposed during childhood 
leaving a larger reservoir of susceptible adults [11]. Alternatively lower birth and 
death rates in transitioning economies may decrease the flow of susceptible 
individuals into the population and increase the longevity of immune individuals, 
increasing the likelihood that an infectious mosquito will feed on an immune 
individual [12]. Differences in clinical presentations between children and adults 
have been suggested [13-15]. However there is little systematic data available 
describing the breadth of presentations in different age groups.
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1.5.2 Other factors -  sex, race, nutritional status, co-morbidities
Based on some national reports and/or hospital activity records, there are higher 
proportions of dengue cases in male than female patients [8,16]. But interestingly, it 
has been shown that female patients have a higher risk of developing dengue shock 
syndrome (DSS) and of dying from this complication than male patients [8,17].
A study in Cuba showed that black persons had a reduced proportion of severe 
disease than white persons [18]. In addition, serologic surveys showed that the 
presence of antibody to dengue virus could be demonstrated in a high proportion of 
Africans and those who are genetically of African origin in Haiti, but the number of 
symptomatic dengue cases reported among these groups was small [19,20]. One of 
the plausible explanations is that there could be presence of a resistance gene in 
black persons.
Several studies have reported that children with malnutrition had a reduced risk of 
severe disease [21,22]. However, recently one study in El Salvador showed that 
there was no association between nutritional status and severity of dengue [23].
Studies in Cuba suggested that co-morbidities such as bronchial asthma, sickle cell 
anaemia and diabetes mellitus could be risk factors for severe disease [18]. Reports 
focused on fatal cases from Singapore and Puerto Rico also showed that there was a 
high proportion of patients who had significant co-morbidity diseases such as 
diabetes mellitus, asthma, etc [24,25].
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1.5.3 Genetic markers
Several host genetic markers such as some human leukocyte antigen (HLA) class I 
alleles, a promoter variant of CD209 (DCSIGN1-336), some tumour necrosis factor- 
a and lymphotoxin-a polymorphism genes and AB blood group have been identified 
as risk factors for severe dengue [26-31]. However, most of the studies to date have 
been small and the results have not been replicated in second populations so the 
significance remains uncertain. Recently however a large genome-wide association 
study from Vietnam has identified susceptibility loci for DSS at MICB and PLCE1, 
and ongoing studies are investigating whether similar associations can be found in 
different ethnic groups [32].
1.6 Dengue epidemiology in Vietnam
Historically, a dengue-like illness was first recorded in the north and the central 
provinces in 1913. In 1929, the southern provinces of Vietnam experienced the first 
of many dengue fever (DF) epidemics. The first DHF-like outbreak in the country 
was identified in 1963 in the Mekong Delta region of southern Vietnam. After that, 
dengue became established as a major public health problem, with tens of thousands 
of cases reported every year. Between 1963 and 1995, there were 1,518,808 DHF 
cases and 14,133 deaths reported. Data from the dengue surveillance programme in 
southern Vietnam showed epidemic peaks of increasing magnitude occurring 
approximately every five years between 1975 and 1987, with a longer gap o f 11 
years preceding a large epidemic involving 119,429 DHF cases and 342 fatalities in
9
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1998 [8]. Figure 1-4 illustrates important aspects of dengue epidemiology in 
Vietnam from 1960 to 2010.
From 1996 to 2008, the annual incidence of hospitalized dengue cases per 100,000 
population in the 20 provinces of southern Vietnam peaked at 450 in 1998, then 
dropped markedly the following year before gradually increasing again over the next 
decade to reach around 250 cases per 100,000 population in 2008. (Figure 1-5 B). 
Similar trends were observed among children and adults at three referral hospitals in 
Ho Chi Minh City -  Children’s Hospitals No.l (CHI) and No.2 (CH2) and the 
Hospital for Tropical Diseases (HTD), with a rapid increase in dengue cases 
documented in adults. The annual dengue caseload at these hospitals steadily 
increased between 1996 and 2009, from around 8,000 to 12,000 cases per year in 
children and from less than 500 to more than 6,000 annual cases in adults (Figure 1- 
5 A) [8].
All four serotypes of DENV circulate concurrently in the south of Vietnam, but a 
single serotype generally dominates over multiple dengue seasons. DENV-3 was 
dominant from 1997 to 1999, followed by DENV-4 from 2000 to 2002. Between 
2002 and 2006, DENV-2 was the major serotype detected in hospitalized patients. 
Currently DENV-1 is the most prevalent serotype, having replacing DENV-2 as the 
predominant lineage in 2007 [33].
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Figure 1-5: Temporal trends in dengue admissions in Ho Chi M inh city, 
Vietnam, 1996-2008 [8].
(A) Bars show the number of inpatients with clinically diagnosed dengue each year at 
the three study hospitals, Hospital for Tropical Diseases (HTD), and Children’s 
Hospitals No.l (CHI) and No.2 (CH2). Lines show the number of dengue cases in 
children aged 15 years or less (triangles) and adults over the age of 15 (circles) 
combined across the study sites. (B) Shown for comparison is the annual incidence of 
hospitalized dengue per 100,000 people in the southern 20 provinces o f Vietnam 
derived from cases reported.
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1.7 Clinical manifestations
Days of illness 
Temperature
Potential clinical issues 
Laboratory changes
Serology and virology
Course of dengue illness:
Figure 1-6: The course of dengue illness. (Taken from WHO Guideline, 2009)
Dengue infection is asymptomatic in a large proportion o f infected persons and 
symptomatic in the rest. Symptomatic dengue infection has a broad clinical spectrum, 
ranging from a non-severe acute febrile illness sometimes with evidence o f mild 
vascular leakage and haemostatic derangements, to a severe form of illness with 
hypovolaemic shock due to plasma leakage, severe bleeding and/or severe organ 
dysfunction [1,34]. Following an incubation period of around 4 to 10 days from the
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bite of an infected mosquito, symptomatic patients may experience 3 clinical stages, 
usually called the febrile, critical and convalescent periods (Figure 1-6) [1].
1.7.1 Febrile period
Dengue patients have a sudden onset of high fever, which usually lasts for 2 to 7 days. 
During this time patients often have headache, myalgia, arthralgia, rash, conjunctival 
injection, and an injected pharynx. Gastrointestinal symptoms such as anorexia, 
nausea, vomiting or diarrhea occur quite commonly but respiratory symptoms such as 
sore throat, runny nose and cough are less commonly found. Mild haemorrhage, 
including skin and mucosal bleeding, may be seen in this period, and the tourniquet 
test, which assesses the fragility of small vessels, may also be positive at this time. 
The tourniquet test is performed by inflating a blood pressure cuff applied on the 
upper arm of the patient to the mid-point between the systolic and diastolic blood 
pressure for 5 minutes. The test is considered positive when 20 or more petechiae are 
observed in one inch square on the volar aspect of the forearm just distal to the 
antecubital fossa [35]. This test has been considered as supportive evidence for a 
clinical diagnosis of dengue, but since spontaneous petechiae are often present 
anyway and the test can be positive in other infections, the sensitivity, specificity and 
diagnostic utility are limited [36]. In terms of laboratory investigations, progressive 
decreases in leucocyte and platelet counts are usually seen in this period, sometimes 
with mild increases in hepatic transaminases. Differentiation between dengue 
infection and other febrile illnesses is not easy at this early stage. Fortunately
14
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complications are unusual at this time and most patients can be managed 
symptomatically at home and don’t need to be hospitalized [1].
1.7.2 Critical period
The majority of patients begin to recover when the fever settles but in a small 
minority of cases (estimated to be less than 5%) the patient deteriorates around the 
time of defervescence, which is usually between days 3 -  7 of illness. Signs of 
vascular leakage including haemoconcentration and ascites/pleural effusions become 
apparent and may persist for 2 -  3 days. If  there is severe vascular leakage, patients 
will develop hypovolaemic shock, usually preceded by warning signs such as 
abdominal pain or tenderness, persistent vomiting, and a rapid increase in liver size. 
Thrombocytopenia and coagulopathy also become worse during this period and as a 
result skin and mucosal bleeding, still usually mild, are more commonly seen. 
However, severe bleeding does occur in some patients, often those with prolonged 
shock, although occasionally also in patients without evidence of vascular leakage. 
Additionally, in some patients major organ dysfunction such as severe liver 
involvement, encephalitis/encephalopathy, and myocarditis may be seen at this time, 
sometimes without signs of significant vascular leakage or shock [1,34].
1.7.3 Convalescent period
After a few days the convalescent period follows with spontaneous reversal of the 
altered vascular permeability and gradual re-absorption of extravascular fluid over the 
next 48 to 72 hours. Overall the clinical condition improves, with regained appetite,
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resolution of gastrointestinal symptoms, and stable haemodynamic status usually 
accompanied by a diuresis. Some patients may develop the typical recovery rash, with 
“isles o f white in the sea o f red” (Figure 1-7). Bradycardia and electrocardiographic 
changes may also be seen. The haematocrit (HCT) returns to normal, in many cases 
after a transient decrease below normal due to the dilutional effect o f the re­
absorption o f leaked fluid back into the intravascular compartment via the lymphatic 
vessel system. The platelet count also improves rapidly in this period. Some patients 
may develop respiratory distress due to severe ascites and/or pleural effusions, 
especially in cases where a large amount of intravenous fluid was given during the 
critical period. Occasionally pulmonary edema may occur if intravenous fluid is still 
given in the convalescent period [1].
Figure 1-7: Recovery rash in convalescent period in an adult with dengue 
1.7.4 Dengue classification
Over the last 20 years there have been many reports describing difficulties in using 
the traditional DF/DHF classification - including difficulties in applying this 
classification for clinical and research purposes, and also increasing numbers of 
reports describing severe cases that were not included within the accepted DHF
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classification system [37-39]. In 2008, after conducting a prospective multicentre 
study across many countries in Southeast Asia and America designed to assess criteria 
for classification according to clinical severity, a WHO expert group suggested a new 
classification [1,40]. In this new classification system, dengue infection is divided into 
2 categories: dengue and severe dengue. The dengue group is further divided into 2 
subgroups: patients with warning signs and those without warning signs (Figure 1-8).
DENGUE z WARNING SIGNS SEVERE DENGUE
1. Severe plasma leakage
2. Severe haemorrhage
3.Severe organ impairment
i warning 
signs
CRITERIA FOR DENGUE ±  WARNING SIGNS
Probable dengue
live in ■' favel t: cfongus indemic area. 
Fever and 1 cl Fie following criteria:
• Nausea. vomiting
• Fash
•  Aches and pcin:
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•  Leukopenia
• Any warning sign
Laboratory-oonfi rimed dengu e
mportant v%hen ro son zt pbsma ieai.co*
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Figure 1-8: Suggested dengue case classification and levels of severity. (Taken 
from WHO Guideline, 2009)
The expert group agreed that “dengue is one disease entity with different clinical 
presentations and often with unpredictable clinical evolution and outcome”. It is
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important to remember that non-severe patients may develop to severe dengue 
whether or not they have warning signs [1].
1.8 Laboratory diagnosis of dengue infection
_Q
Figure 1-9: Dengue virus, antigen and antibody responses used in diagnosis [4].
Because dengue infection has a wide clinical spectrum, laboratory diagnosis is 
important to confirm the disease. A variety o f different laboratory tests are available 
for diagnosis -  acute dengue infection is usually considered confirmed by any one o f 
the following results a) isolation of virus, b) detection o f viral nucleic acid, c) 
detection o fN Sl  and d) seroconversion of IgM or IgG. The time frame for a positive 
result according to these different tests varies (Figure 1-9). Virus isolation, viral 
nucleic acid and NS1 detection are useful for dengue diagnosis in the early phase up 
to around day 5 o f illness, while serology is useful for dengue diagnosis after the 
acute phase [1,4]. A positive NS1 result may persist for up to two weeks however,
18
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although the magnitude and kinetics of the response do vary according to the serotype 
involved and whether the infection is primary or secondary [41]. After the acute 
phase, when the virus or antigens disappear, IgM and IgG antibodies start to rise, with 
different patterns seen in primary and secondary infections. These antibodies may 
persist for several months, so strictly speaking, if seroconversion is not documented, 
the presence of IgM or high levels of IgG is taken as evidence of recent rather than 
acute dengue infection [4]. The common laboratory tests for confirmation of dengue 
infection in clinical practice and in research are described below.
1.8.1 Serological tests
1.8.1.1 IgM antibody-capture enzyme-linked immunosorbent assay (MAC ELISA)
MAC ELISA is a sensitive and relatively specific method for detection of DENV- 
reactive IgM in serum or plasma. The antigens used in this technique are usually 
inactivated viral particles. The advantage of this assay is that it is relatively 
inexpensive and simple. The principle drawbacks of this are a) it is not sensitive in the 
first few days of illness, b) it is cross-reactive with other flaviviruses such as Japanese 
encephalitis, St Louis encephalitis and yellow fever, but this is not a problem if 
appropriate specificity controls are included in the assay, and c) there are occasional 
reports of false positive results with malaria, leptospirosis. Different commercial 
assays (ELISA and rapid test) are available but they have variable sensitivity and 
specificity, with ELISA tests better than rapid tests [1,4].
19
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1.8.1.2 IgG antibody-capture enzyme-linked immunosorbent assay (GAC ELISA)
This assay uses similar principles and antigens as the IgM Capture ELISA. In general 
however, IgG ELISA lacks specificity within the flavivirus serocomplex group. 
Together with MAC ELISA, GAC ELISA on paired sera can be used to confirm acute 
dengue infection. It is also used to discriminate between primary and secondary 
infections by assessing the IgM/IgG ratio. However the cut-off for this ratio is 
variable and not well defined [1,4].
1.8.2 Dengue nucleic acid detection
Since the 1990s it has been possible to diagnose dengue infection by detecting dengue 
RNA in tissue or plasma samples using reverse transcriptase polymerase chain 
reaction (RT-PCR) methods, with a variety of different in-house assays. Infecting 
serotypes of DENV can be detected based on the differences in amplicon sizes. RT- 
PCR can be single RT-PCR or one-step multiplex RT-PCR. Alternatively, real-time 
RT-PCR using specific primers and fluorescent probes for each dengue serotype can 
be used. Real-time RT-PCR assays can either identify one serotype at a time - 
“singleplex” - or can detect all four serotype from a single sample - “multiplex”. RT- 
PCR and real-time RT-PCR can determine viral titre in the early febrile period, which 
is considered to be an important predictor of subsequent disease severity. However, 
this assay is not suitable for routine diagnosis in all settings because it is expensive in 
terms of specialized training, equipment and reagents [1,4].
20
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1.8.3 DENV NS1 detection
DENV NS1 is a glycoprotein secreted into the peripheral blood. Many tests including 
antigen-capture ELISA and lateral flow antigen detection systems have been 
developed to confirm dengue infection by identifying NS1 protein [4]. The 
specificity of these tests is very high (approximately 100%), but the sensitivity is 
variable in different studies [42-44]. The sensitivity depends on the day of illness the 
sample was taken. The highest sensitivity is seen on the first three days of illness [42]. 
However, NS1 has been detected up to two weeks after the onset of illness, when 
DENV RNA can no longer be detected by polymerase chain reaction (PCR) [45]. In 
addition, primary infection has relatively higher sensitivity compared to secondary 
infection [42]. At present commercial NS1 detection tests can’t discriminate the 
infecting virus serotype, although a serotyping NS1 ELISA that can detect virus 
serotypes with overall sensitivity of 76.5% and specificity of 100% was developed 
recently in Thailand [46].
1.9 Clinical management [1,47]
There is no specific drug for treatment of dengue infection at the present time. The 
general rule for good management is to diagnose patients early, attempt to identify 
predictors of severe forms of disease as soon as possible, and to give suitable 
supportive treatment for the patient. The particular management strategy depends on 
whether patients are diagnosed as dengue (with and without warning signs) or severe 
dengue.
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1.9.1 Dengue without warning signs
For most patients in this group, it is safe to manage them at home in the early febrile 
period. Hospital admission may be indicated if patients live far away with limited 
access to health care, or if there is no competent person to care for them at home. 
Parents or guardian should be instructed clearly about the following things:
- Early recognition of warning signs or evidence of severe dengue. They should return 
with the patient to the health care system promptly if they have any of these signs.
- To control fever using physical methods such as fans, tepid sponging etc., and to 
provide antipyretic therapy with paracetamol only. Aspirin and other non-steroidal 
anti-inflammatory drugs are contraindicated.
-T o  rehydrate with oral rehydration salts (Oresol) or similar preparation, together 
with a light diet.
-To return to the health care system with the patient for daily assessments during the 
critical period until the fever has gone for at least 24 hours.
On daily assessment, health care workers should look carefully for warning signs 
and/or evidence of severe dengue, and the HCT and platelet count should be checked 
at each visit. The changing trend of the HCT and platelet count can be very helpful 
both for diagnosis of dengue infection and to identifying the magnitude and speed of 
onset of vascular leakage. If patients have warning signs, or a rapid and severe 
increase in haemoconcentration, they must be admitted. Otherwise most patients can 
be managed at home provided they can tolerate oral fluids.
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1.9.2 Dengue with warning signs
It must be kept in mind that both dengue with and without warning signs may develop 
to severe dengue, although patients with warning signs do have a higher risk of 
developing to severe dengue. Thus patients with warning signs must be admitted. 
Management of these patients includes:
- Close observation to allow early recognition of severe dengue in the critical period
- Antipyretic therapy and oral dehydration should be given as indicated for outpatient 
management
- Intravenous fluid therapy with isotonic crystalloid solutions is indicated for those 
patients with repeated vomiting, a very high or rapidly rising HCT or any signs of 
cardiovascular compromise. The minimum amount of fluid that can maintain 
hemodynamic status and give good urine volume (at least 0.5 ml/kg/hour) should be 
prescribed. The intravenous fluid infusion should be stopped if patients can tolerate 
oral dehydration and the hemodynamic status is stable.
- Careful observation including regular pulse and blood pressure monitoring until 
fever has gone for at least 24 hours without antipyretics, detailed fluid intake and 
output. HCT and platelet counts should continue to be checked at least once a day. 
Other blood investigations may be indicated depending on the clinical picture.
1.9.3 Severe dengue
Management is supportive and depends on the clinical pattern of severe disease seen.
The general principles of management of hypovolaemic shock due to plasma leakage,
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and of severe bleeding, will be discussed here. Management of severe liver 
involvement and encephalopathy is similar to the standard treatment of these 
disorders.
1.9.3.1 Management of hypovolaemic shock due to plasma leakage
Dengue patients with hypovolaemic shock due to vascular leakage require emergency 
resuscitation. These patients should be admitted to a high dependency or intensive 
care unit (ICU), staffed by clinicians and nurses experienced in the management of 
severe dengue. Judicious intravenous fluid resuscitation is the mainstay of the 
treatment, with most endemic countries establishing formal guidelines for the rate, 
volume and type of fluid to be used in particular circumstances, in order to try to 
prevent iatrogenic volume overload. Briefly, plasma losses must be replaced 
immediately and rapidly with isotonic crystalloid solutions, or with colloid solutions 
in cases with profound shock (no recordable pulse or blood pressure, or pulse pressure 
< 1 0  mmHg). A reducing schedule of replacement with crystalloid solutions should 
then be continued for 24 to 48 hours to counteract ongoing plasma losses and 
maintain an effective circulation until the re-absorptive phase of the illness begins. 
Further boluses of colloid resuscitation may be needed for recurrent shock due 
excessive plasma losses, but must be given with great care and frequent clinical 
reassessment to prevent fluid overload or pulmonary edema in such patients. The aims 
of fluid resuscitation are to improve central and peripheral circulation, and to improve 
organ perfusion until the altered vascular permeability reverts spontaneously to 
normal. Careful monitoring of vital signs, mental status, and fluid input/output,
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together with serial HCT measurements, is essential for assessing the patient’s 
response.
1.9.3.2 Management of severe bleeding
In children, severe bleeding is almost always seen in association with profound or 
prolonged shock. But in adults, it may be seen in patients without shock. However, 
particularly in patients with DSS and altered gut motility, internal bleeding may not 
be apparent for many hours until the first melaena stool is passed. Patients with overt 
or suspected severe bleeding must be admitted to ICUs with access to blood 
transfusion services. Fresh whole blood or packed red cells and oxygen are urgently 
indicated for those patients. Platelet concentrates, fresh frozen plasma and 
cryoprecipitate may be indicated for some patients with severe bleeding to correct 
associated coagulation disturbances. However blood products should be given with 
caution because of the risk of fluid overload and other serious adverse effects. Careful 
monitoring of bleeding severity, based on frequent haemodynamic monitoring and 
repeated clinical assessments, together with rapid access to serial haematocrit 
measurements ideally using an on-site micro-haematocrit centrifuge, is important to 
assess the patient’s response, and to direct therapy.
1.10 Pathogenesis
1.10.1 Pathogenesis of vascular leakage
Systemic vascular leakage is the most important phenomenon in dengue. Although 
there has been considerable progress in understanding relationships between
25
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immunological derangements and dengue disease, the underlying pathogenic 
mechanisms responsible for vascular leakage are still poorly understood. The well 
known “antibody-dependent enhancement” hypothesis suggests that low 
concentrations of maternal dengue antibodies in infants, or residual heterotypic non­
neutralising antibodies from an earlier infection in older patients, bind to a new virus 
of another serotype introduced in the current infection, and amplify uptake of this 
virus into cells of the macrophage-monocyte lineage encouraging increased viral 
replication. The resulting increase in viral load then drives an immunopathogenic 
cascade that alters microvascular structure or function in some way, thereby resulting 
in a transient increase in permeability [48,49]. Rapid mobilisation of serotype cross­
reactive memory T cells has been proposed as an alternative mechanism to trigger the 
inflammatory cascade and many other factors such as differences in viral virulence, 
molecular mimicry, immune complex and/or complement mediated dysregulation, 
genetic predisposition and other host factors such as age and nutritional status, have 
been shown to correlate with disease severity in terms of vascular leakage [48,50].
The pathway by which such immunological derangements act on the endothelial 
barrier and results in increased vascular leakage is not known, at least partly due to 
lack of understanding surrounding normal microvascular permeability mechanisms. 
However over the last 20 years there have been considerable advances in 
understanding the structure and function of the endothelial cells and their associated 
surface glycocalyx layer with respect to microvascular permeability in health [51,52]. 
The glycocalyx layer, a highly anionic fibre matrix of proteoglycans,
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glycosaminoglycans (GAGs) and adherent plasma proteins, is located on the luminal 
surface of the vascular endothelium and anchored in the plasma membrane of the 
endothelial cells. It is now considered to be the primary barrier to the movement of 
water and molecules, restricting movement of such molecules according to their size, 
charge and shape, while the underlying endothelial cells appear to function as the 
secondary barrier [53]. Very few studies have examined structural effects of dengue 
infection in the human micro vasculature and only minor non-specific histological 
changes have been shown in the microvessels, with no convincing evidence that the 
virus infects endothelial cells in vivo [54-56]. However, visualization of the surface 
glycocalyx layer is currently not possible using conventional microscopy techniques, 
so the effects of dengue infection on this layer have never been evaluated.
One way to investigate possible changes in the surface endothelial glycocalyx layer is
to study the characteristics of the proteins lost during dengue infections, focusing on
the size and charge of the molecules that leak. Previous work from Oxford University
Clinical Research Unit (OUCRU) looking at fractional clearance estimations for
endogenous proteins has demonstrated firstly that smaller proteins were relatively
more affected than larger proteins, and secondly that albumin, normally protected
from leakage by its strong negative charge, showed a clearance pattern similar to
transferrin - i.e. a neutral molecule of similar size. These results indicate that size
selectivity is at least partially retained during acute dengue infections, and suggest
that charge selectivity is impaired. In the same study urinary GAG excretion was
significantly increased in children with DSS, suggesting a possible role for disruption
of the surface glycocalyx in the pathogenesis of the vascular leak [57]. Recently a
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more detailed examination of protein clearances using a dextran clearance technique 
found no differences in dextran fractional clearances at serial time-points (critical 
period of illness, one and three month follow-up) in dengue patients who had clear 
evidence of vascular leakage, and also no difference in comparison with the results 
from a group of healthy persons. One possible explanation could be that during 
dengue infections endogenous proteins are displaced from the glycocalyx layer 
altering the permeability characteristics of the endothelial complex -  however, during 
the dextran infusion the dextran molecules may replace the lost proteins and 
temporarily restore normal permeability [58].
1.10.2 Pathogenesis of haemorrhage
Almost all symptomatic dengue patients have a coagulopathy as well as 
thrombocytopenia. Although many small studies about the coagulopathy in dengue 
infection have been carried out during the last 30 years, the pathogenesis remains 
poorly understood. Debate continues about whether true disseminated intravascular 
coagulation (DIC) occurs, and about whether fibrinolysis is activated or impaired in 
dengue infection [59,60].
1.10.2.1 Normal haemostasis
In order to identify and understand the possible coagulation abnormalities that may 
occur during dengue infections it is necessary to consider the main mechanisms 
controlling haemostasis in the healthy state.
Normal haemostasis depends on a carefully coordinated balance of three pathways, as
shown in Figure 1-10. The pro-coagulant (blue), anti-coagulant (red) and fibrinolytic
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(green) pathways act together regulated by proteins expressed on the vascular 
endothelial surface and on circulating blood components. The figure emphasizes the 
role of the tissue factor/factor Vila complex that forms when a blood vessel is injured, 
in activating the pro-coagulant pathway. This activation results in generation of 
thrombin, which then acts on fibrinogen forming fibrin and resulting finally in the 
creation of the fibrin blood clot. Table 1-1 summarizes the principle characteristics of 
the coagulation factors involved in thrombin generation. As discussed above, two 
characteristics of plasma proteins that are likely to be influence their capacity for 
leakage are the molecular size and the charge of individual proteins. The molecular 
weights of many of the coagulation proteins listed are similar to that of albumin 
(69,000 Daltons) and therefore they might be expected to leak, especially in patients 
with increased vascular permeability. With respect to charge, the isoelectric point (pi) 
is the pH at which a particular molecule carries no net electrical charge; at a pH below 
their pi proteins carry a net positive charge, whilst above it they carry a net negative 
charge. Most coagulation proteins for which the pi is known, would therefore carry a 
negative charge at physiological pH.
The thrombin generation process is carefully regulated by thrombin inhibitors (tissue 
factor pathway inhibitor and antithrombin) acting together with the different elements 
of the protein C pathway, to prevent overproduction of thrombin. Finally the 
fibrinolytic pathway functions to convert plasminogen to plasmin, which then breaks 
down fibrin to fibrin degradation products (FDPs), thus helping to remove fibrin and 
balancing the forward action of the pro coagulant pathway [61].
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Chapter 1 - Introduction
Dysregulation of any of the three pathways can result in coagulation abnormalities. 
Conventionally the first step in assessing possible abnormalities of the coagulation 
cascade is to perform screening tests such as the prothrombin time (PT), activated 
partial thromboplastin time (APTT), plasma fibrinogen levels and FDP levels. The PT 
and APTT are in vitro tests that are used to assess two pathways of coagulation 
activation: the “extrinsic” pathway (activation of coagulation by tissue factor) and the 
“intrinsic” pathway (activation of coagulation by the contact system), respectively. 
This division of coagulation activation bears only a limited relationship to the way 
coagulation is activated in vivo (Figure 1-10) but remains a useful concept for 
interpreting the results of laboratory investigations. The PT measures the time to clot 
formation in test plasma after addition of an optimal concentration of a tissue extract 
(thromboplastin) containing tissue factor - it is largely dependent on factors of the 
“extrinsic” pathway (factor VII) and the common pathway (factor X, V, II and I). The 
result for an individual sample, measured in seconds, will vary according to the type 
of thromboplastin used. The International Normalized Ratio (INR) is a standardized 
way of expressing the results. Each manufacturer gives an International Sensitivity 
Index (ISI) value for any thromboplastin they produce. The ISI value shows how a 
particular batch of thromboplastin compares to an international reference 
thromboplastin. The INR is the ratio of a patient's test result to the log mean normal 
PT from 20 normal donors, raised to the power of the ISI value for the analytical 
system used: INR = (PT patient/log mean normal PT)ISI [63,64].
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On the contrary, the APTT measures the time to clot formation of test plasma after 
activation of the contact factors, without added tissue thromboplastin. It is dependent 
on factors of the “intrinsic” pathway (factor XII, XI, IX and VIII) and the common 
pathway (X, V, II and I) [63,64]. In clinical practice, the APTT is commonly used for 
monitoring the effect of heparin therapy. However, assays that measure anti-factor Xa 
activity have become available recently and are generally considered to be more 
effective for monitoring anticoagulant therapy [65]. As yet this type of test is not 
readily available in Vietnam.
In addition to the requirement for normal levels of functioning coagulation proteins, 
since the endothelial surface is an important participant in the haemostatic process, if 
endothelial cells or other components of the microvascular barrier are lost from the 
vessel wall following a pathological insult, then haemostasis may be affected. 
Secondly if endothelial cells are released into the circulation, becoming circulating 
endothelial cells (CECs), they may themselves participate in the haemostatic process, 
possibly by the expression of active molecules such as thrombomodulin or tissue 
factor on the cell surface [66]. For example, it has been shown that CECs isolated 
from patients with sickle cell disease express tissue factor that is functionally active in 
vitro [67].
Both coagulation and inflammation are essential to an effective host response to
infection. Increasingly the molecular links between sepsis induced inflammation,
haemostasis and endothelial dysfunction are being elucidated [68,69]. There appears
to be an intricate relationship between the systems, whereby inflammation leads to
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activation of coagulation, and coagulation also considerably affects inflammatory 
activity. Inflammation induced activation of coagulation is primarily caused by 
upregulation of tissue factor expression on monocytes, macrophages and endothelial 
cells, release of vWF leading to platelet aggregation and adhesion to the sub- 
endothelial surface, and down regulation of the fibrinolytic and anticoagulant 
pathways.
1.10.2.2 Pathogenesis of haemorrhage in dengue infection 
Early studies (before the year 2000)
After the emergence of DHF in Southeast Asia in the 1950’s, many studies about the 
coagulopathy were conducted in the region, especially in Thailand. However sample 
sizes were invariably small and the studies were frequently biased towards recruiting 
particular groups of severe patients. Thrombocytopenia was the major finding and this 
correlated with disease severity in terms of shock [70]. There was also evidence for 
increased destruction of platelets demonstrated by shortened duration of survival of 
transfused platelets [71]. It has been suggested that increased destruction of platelets 
is related to immune complexes containing dengue antigen found on platelet cell 
surfaces [72]. Also, evidence of decreased bone marrow production of platelets has 
been shown, with marked depression of all bone marrow elements and the presence of 
vacuoles in megakaryocytes in marrow aspirates obtained from day 1 to 4 of illness 
[73]. Platelet function was also found to be abnormal in dengue infection. In the acute 
phase of the disease, platelet aggregation in response to adenosine diphosphate was
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impaired, with concurrent increases in plasma p-thromboglobulin and platelet factor 4 
indicating that platelet secretory activity was increased [74].
In terms of screening coagulation tests, in addition to thrombocytopenia most of the 
early studies found normal or slightly prolonged PT, significantly prolonged partial 
thromboplastin time (PTT), mild to moderate reduction of fibrinogen levels and 
slightly or moderately increased FDPs [70,75,76]. Only a few studies measured 
specific coagulation factors in small numbers of patients. It was shown that factor II, 
V, VII, VIII, IX, X and XII levels were slightly decreased [76]. At this time, 
coagulopathy in dengue was thought of as a mild to moderate DIC although without 
clear evidence of activation of the pro-coagulant pathway or of the presence of FDPs.
In addition, based mainly on investigation in animals and in vitro experiments some 
authors implicated several possible mechanisms for disturbances in the fibrinolytic 
pathway in DHF. Antibodies to the dengue E protein that cross-react with 
plasminogen and thus might influence the fibrinolytic pathway were detected in 75% 
of Thai patients with dengue [77]. These antibodies were later shown to correlate with 
the occurrence of haemorrhage but not capillary leak or thrombocytopenia in Tahitian 
children infected with dengue [78]. Similar antibodies, raised in mice and rabbits, 
have been demonstrated to inhibit plasmin activity in an in vitro system [79]. 
However the pathogenic role of the antibodies remains uncertain since the animals did 
not develop any bleeding problems, and the authors also demonstrated that in humans 
the antibodies persist for several months, by which time the patients had recovered 
fully. Antibodies to the dengue NS1 protein raised in mice have also been shown to
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cross react with human fibrinogen, platelets and endothelial cells and this may have a 
role in the pathogenesis of DHF [80]. In an in vitro system, it has been demonstrated 
that dengue viral isolates are able to activate plasminogen in the absence of thrombin 
generation (usually considered a necessary step prior to plasminogen activation), and 
that the plasmin so generated could degrade both fibrin and fibrinogen [81].
Recent studies
Several more recent studies have examined potential mechanisms underlying the 
observed platelet abnormalities in more detail. Using an in vitro assay, a group in 
Japan found that during the acute phase of secondary dengue there was a significant 
increase in phagocytosed platelets within macrophages compared with the findings in 
healthy persons and this correlated inversely with the platelet count. This suggests 
that phagocytosis of platelets is one of the mechanisms responsible for 
thrombocytopenia [82]. Another group demonstrated expression of various dengue 
proteins within platelets experimentally infected in vitro and within platelets isolated 
from dengue patients, using a variety of different techniques such as flow cytometry, 
Western blot analysis, double immunofluorescence staining and confocal microscopy. 
This group also identified dengue viral-like particles within platelets from dengue 
patients using electron microscopy. These findings suggest that the dengue virus may 
replicate in platelets and may partly explain the thrombocytopenia and platelet 
dysfunction that is characteristic during infection [83].
In terms of the coagulopathy recently some groups have focused on looking for 
evidence of specific derangements in the three major pathways -  pro-coagulant, anti­
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coagulant and fibrinolytic -  during disease evolution through the various different 
stages [84-90]. Table 1-2 summarizes the main findings of these studies. In the light 
of these findings there has been much debate as to whether true DIC, with primary 
activation of the pro-coagulant pathway leading to secondary effects on the other 
pathways, occurs or whether the primary derangements relate to the anticoagulant 
and/or fibrinolytic pathways directly.
Work in pediatric patients representing the spectrum of infection from mild to severe 
disease at OUCRU found that thrombocytopenia, prolongation of the APTT and 
reduction in plasma fibrinogen levels were the three typical coagulation disturbances, 
without clear prolongation of PT or presence of FDPs; and all of these typical 
disturbances were strongly correlated with vascular leakage severity. The findings 
suggest that the primary abnormality is not likely to represent a true DIC. Given that 
plasma proteins leak from the circulation one possible mechanism could involve 
leakage of coagulation proteins, most of which are small in size (see Table 1-1), from 
the intravascular to the interstitial fluid compartment [86,90]. An alternative or 
additional explanation could involve disruption of the surface glycocalyx layer during 
infection, resulting in release of molecules such as the GAG heparan sulfate (HS) into 
the circulation. HS is a major constituent of the endothelial surface glycocalyx, is a 
known receptor for dengue virus and is also known to have anticoagulant properties 
similar to heparin -  if released into the circulation it could result in prolongation o f 
the APTT [90]. As mentioned above increased urinary GAG excretion has been 
demonstrated during acute dengue, although plasma levels have not been measured 
previously [57].
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Chapter 1 - Introduction
1.11 Knowledge gaps and objectives of this thesis
As discussed above the pathogenesis of the coagulopathy associated with dengue 
infection remains poorly understood. In addition to thrombocytopenia, an increase in 
APTT and a reduction in fibrinogen levels are the two most consistent abnormalities 
detected. There has been much debate as to whether true DIC occurs and other 
plausible mechanisms have been suggested, including leakage of coagulation proteins, 
direct effects of the virus on fibrinogen activation, and/or presence of a circulating 
anticoagulant.
In addition, data from adults, the group in which bleeding appears to be a more 
common problem [13-15], are very limited. It is possible that co-morbid conditions, 
such as pre-existing liver disease or peptic ulcer disease may explain the apparently 
greater susceptibility to bleeding complications among adult dengue patients. And 
finally insights from recent advances in our understanding of the complex molecular 
interactions between haemostasis, sepsis, and vascular endothelial structure and 
function, have yet to be applied to the problem. For example, in other diseases with 
endothelial involvement CECs have been shown to be useful biomarkers of disease 
and are also thought to participate in the pathogenesis of some coagulation disorders, 
possibly by the expression of active molecules such as thrombomodulin or tissue 
factor on the surface of the cells [66].
In addition to contributing to the overall body of knowledge about dengue 
pathogenesis, better understanding of the mechanisms underlying the haemostatic
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derangements associated with dengue may be important for several practical reasons. 
Firstly platelet transfusions are becoming increasingly common in some centres in 
Asia, without evidence that this is beneficial and with a small but definite associated 
risk. Detailed knowledge of the natural history of the thrombocytopenia and 
coagulopathy may help to inform policy on when to transfuse platelets or other blood 
products, and/or may form the basis for a formal intervention study designed to 
address these questions. Finally suggestions for novel or alternative management 
strategies may arise from improved knowledge of interactions occurring at the 
molecular level -  if for example a circulating anticoagulant is identified, this could be 
a potential target for an inhibitor.
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Objectives of this thesis:
1. a) To describe the clinical and basic laboratory features seen in a large cohort of 
prospectively recruited adults with dengue infection in comparison with the 
findings observed in children recruited during the same dengue season.
b) To describe the liver involvement seen in adults with dengue infection and to 
investigate possible effects of this on the coagulopathy as well as the effect of co- 
infection with hepatitis B or C viruses on liver enzymes and coagulation tests.
2. To explore the mechanisms underlying the increase in APTT that is typically seen 
during dengue infections and to address the following specific hypotheses
a) the APTT increase is related to a decrease in coagulation protein levels due to 
leakage of these proteins horn the intravascular compartment
b) the APTT increase is related to the presence of a circulating anticoagulant, such 
as the endothelial glycosaminoglycan heparan sulfate
3. To describe the pattern of CECs and to determine whether there is a correlation 
between numbers of CECs and bleeding manifestations, coagulopathy, and/or the 
severity of vascular leakage.
42
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This chapter describes the general clinical, laboratory and statistical methods used for 
the research presented in Chapters 3 -  5 of this thesis. Specific methods used for 
particular studies will be presented in the relevant chapters.
2.1 Patient cohorts and clinical methods
A series of prospective observational studies of patients presenting with febrile illness 
consistent with dengue were carried out over several years. All the clinical studies 
took place at HTD of Ho Chi Minh City. At HTD, patients of 15 years of age or over 
are admitted to adult wards while those below this age are managed on paediatric 
wards. The hospital currently admits 7,000 - 10,000 patients with suspected dengue 
each year, of whom around two-third are aged 15 or over.
2.1.1 The main adult cohort
Adults admitted to HTD with clinically suspected dengue were eligible for enrolment. 
Recruitment was targeted to include all patients with suspected dengue admitted to the 
Adult Intensive Care Unit (AICU) during the two-year period between September 
2006 and September 2008 as well as a representative sample of male and female 
patients (200 each) admitted to the infection wards during 2007.
Within 24 hours of admission designated senior doctors on the infection wards tried to
recruit all patients with suspected dengue in specific bays on the wards; diagnostic
criteria were not specified as we aimed to include the full spectrum of hospitalised
cases. I then collected detailed clinical information later that day, and daily for the
duration of the hospital stay, using a standard case report form (CRF). A venous
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Chapter 2 ~ Materials and Methods 
blood sample was obtained each day for clinical and diagnostic investigations as 
detailed below. Additional investigations and management were at the discretion of 
the treating physicians. Hospital policy dictates that any patient with suspected 
dengue on the infection wards about whom there is any concern must be transferred to 
one of the ICUs for close observation. I continued to observe daily any patients who 
were transferred from the infection wards to the AICU. After discharge all patients 
were invited to attend for review 2-4 weeks later, when a final blood sample was 
obtained.
2.1.2 Paediatric cohorts
Detailed observational studies of children with suspected dengue have been ongoing 
for several years at the hospital [86,90,91]. During the time-period of my adult 
studies, paediatric studies with the following enrolment criteria were in progress: a) 
children 2-15 years old admitted to the Paediatric Intensive Care Unit (PICU) with 
clinically suspected dengue and severe complications; b) children 5-15 years old 
admitted to the paediatric infection wards with suspected dengue. As with the adult 
studies eligibility criteria on the infections wards were deliberately broad to allow the 
study physicians to invite all potential subjects with suspected dengue to participate. 
However, unlike the main adult cohort, due to staff workload constraints on PICU, 
children were only eligible for study recruitment on this ward once major 
complications developed (i.e. children transferred to PICU for close observation who 
did not develop shock or other complications were not included). For my comparative
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studies I chose all children recruited to these studies during the same calendar period 
as the adult patients were recruited.
The protocols for the paediatric studies were similar to those of the adult studies. 
Briefly, after recruitment, demographic information, clinical history and examination 
details were recorded on standard CRTs and all subjects were followed daily by 
trained study physicians until discharge. In all cases daily EDTA plasma samples 
were obtained for platelet count and HCT measurements, but other sampling was kept 
to the minimum necessary for the particular studies in progress at any time. 
Management remained in the hands of the ward clinicians following hospital policies. 
All participants were invited for review around one month after discharge, when final 
blood samples were obtained.
2.1.3 The adolescent and young adult cohort for the study on circulating 
endothelial cells
Teenagers and young adults aged between 12 and 25 years admitted to HTD with 
clinically suspected dengue were eligible for enrolment into this study. Two main 
groups of patients were eligible -  a) patients with suspected dengue admitted to the 
infection wards on or before day 3 of illness and b) patients admitted to the ICUs with 
suspected dengue up to and including day 6 of illness. After full dengue diagnostics 
had been performed (as described below), participants who were subsequently 
confirmed to have OFI rather than dengue formed one control group. A second 
disease-control group consisted of patients admitted to the infection wards or ICUs
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with smear positive malaria within the first week of illness; malaria was chosen as a 
disease in which endothelial involvement also occurs and which is seen with 
reasonable frequency at HTD. However the upper age limit for recruitment was 
increased to 35 years for the malaria group, to take into account the local disease 
epidemiology. Finally a group of healthy volunteers aged 18-25 years was also 
recruited, to allow identification of the normal range for CECs in a Vietnamese 
population of a similar age.
The clinical protocol for this study was similar to those described above. I saw each 
patient daily, recorded detailed history and examination findings on a standard CRF, 
categorised each subject for the severity of vascular leakage and bleeding after 
discharge, and invited all patients for review several weeks later. As before additional 
investigations and management were at the discretion of the physicians responsible 
for patient care. However as well as the standard haematological and biochemical 
investigations described below for the adult cohort, additional 2 ml EDTA samples 
were obtained for enumeration of CECs at intervals during the course of the acute 
illness and at the follow-up visit. To prevent artificial increases in CEC numbers due 
to traumatic detachment of CECs during venepuncture, a large bore (19G) butterfly 
needle was used and at least 2 ml of venous blood was first obtained using one 
syringe, to be used for the full blood count, coagulation tests etc., before the CEC 
sample was taken into a second separate syringe [92]. All samples were stored on ice
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and quickly transferred to the research laboratory for immediate enumeration of 
CECs.
2.2 Ethics
Ethical approvals were obtained for all studies from the Scientific and Ethical 
Committee of the HTD of Ho Chi Minh City and the Oxford University Tropical 
Research Ethics Committee. All subjects or their parent/guardian gave written 
informed consent before enrolment into the patient cohorts described above. Similarly 
all the healthy volunteers gave written informed consent for inclusion in the relevant 
studies. All studies were carried out in accordance with international standards for the 
ethical conduct of research involving human subjects.
2.3 Definitions for clinical complications, disease severity and clinical periods in 
dengue infection
Definitions for clinical complication and disease severity are shown in Table 2-1. 
Following the new WHO guidelines vascular leakage was classified primarily 
according to whether or not the patient developed hypovolaemic shock [1].
To investigate changes throughout the course of illness, we divided the clinical course 
of dengue infection into 3 clinical periods: early febrile period (Day 1 -  3 of illness), 
critical period for complications such as shock (Day 4 - 6), and convalescent period 
(Day 7-10).
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Chapter 2 -  Materials and Methods
2.4 Laboratory methods
2.4.1 Standard laboratory tests
Haematology: For all patients, a full blood count was performed at least once daily during 
the course of illness and at the follow-up visits in the routine haematology laboratory of 
HTD using the ADVIA 120 haematology analyzer (Bayer, Germany). On the ICUs, HCT 
measurements were also performed on the ward as frequently as required for clinical 
management. Overall percentage HCT change (haemoconcentration) for each patient was 
calculated as the percentage difference between the peak HCT and the baseline HCT value, 
over the baseline value. Peak HCT was chosen from all values recorded between days 3 and 
8 of illness if at least 3 days of serial HCT data was available. For the baseline HCT, the 
lowest value documented before day 3 of illness or at the follow-up visit was used; if 
neither was available the local population mean for age and sex was used (from a reference 
database for more than 1000 healthy Vietnamese children and 850 healthy Vietnamese 
adults, unpublished data). In addition, because HCT values can be markedly affected in 
patients with severe bleeding overall percentage HCT change was not calculated for those 
patients. Platelet nadir was chosen from all values between day 3 and 8 of illness if at least 3 
days of serial platelet counts were available.
Coagulation tests are performed infrequently in the HTD laboratories. For the first 200 
patients recruited to the main adult study and all the patients recruited to the CECs cohort, 
citrated plasma samples were obtained for screening coagulation tests at specified intervals 
during the course of disease -  febrile, critical and convalescent -  but instead of using the
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HTD lab the plasma was separated and stored at -80 degrees as soon as possible after 
sampling. Subsequently coagulation testing was performed in batches in the OUCRU 
research laboratories using an ST4 Hemostasis Analyser and reagents from Stago (France). 
The following screening tests were done a) PT using STA NEOPLASTINE Cl PLUS, b) 
APTT using C.K. PREST, c) plasma fibrinogen levels using FIBRIN PREST and d) semi- 
quantitative D-Dimer using D-DI test. For the data analysis only results from samples 
without evidence of haemolysis or clot formation, that were separated and frozen within 6 
hours, were included.
Biochemistry: For the main adult cohort bilirubin and transaminase levels were also 
performed at intervals during the course of disease, but using the routine HTD laboratories. 
In addition, hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnostics were 
performed on stored convalescent or follow-up samples using Abbott AxSYM reagents 
(Illinois, USA). Anti-hepatitis B core antibody (antiHBc) was checked as an initial screen 
for all adult patients, with hepatitis B surface antigen (HBsAg) and anti-hepatitis B core IgM 
(antiHBc IgM) performed if the test was positive. Anti-hepatitis C antibody (antiHCV) was 
checked on samples from the first 200 adults enroled in the study.
Quality Control: In accordance with the International Organization for Standards (ISO) 
quality accreditation, the haematology and biochemistry laboratories of HTD have an 
ongoing quality assessment program that includes internal quality control every day and 
external quality assessment every month, run by the Center for Standardization and Quality 
Control in Medical Laboratories of Ho Chi Minh City. The system operates for all categories 
of laboratory tests performed at HTD. For the coagulation tests that we performed in the
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OUCRU laboratories, we checked internal quality control every day using normal and 
abnormal control samples from Stago.
2.4.2 Dengue diagnostic tests
Dengue diagnostic capture IgM and IgG ELISA assays were performed using paired 
enrolment and convalescent specimens and reagents provided by Venture Technologies 
(Sarawak, Malaysia). The techniques used and interpretation of results were as previously 
reported (Figure 2-1) [42]. To define immune-status the ratio of IgM to IgG on or after day 
6 of illness was used; a ratio > 1.78 defined the infection as primary and one < 1.2 as 
secondary [96]. Patients with ratios between these values, or in whom the results of 
enrolment and convalescent specimens differed, were considered unclassifiable.
Using the enrolment specimen, DENV real-time RT-PCR was carried out as previously 
described for a) all patients in the paediatric cohorts (who were generally admitted early) 
and b) all patients from the main adult cohort who were enrolled within the first 5 days of 
illness, and who had negative or inconclusive serology [42]. A new one-step real-time 
multiplex RT-PCR assay had been developed in our research lab by the time the 
adolescent/young adult cohort was recruited and this new technique was therefore used for 
the diagnostic work-up in this group of patients [97].
If both serology and PCR were negative or inconclusive, assays for NS1 were performed 
using Biorad Platelia™ Dengue NS1 Antigen kits following the manufacturer’s instructions. 
Patients in whom all dengue diagnostics were conclusively negative, in whom there was no 
evidence of any other infectious disease, and who recovered without antibiotic therapy, were 
considered to have had OFI.
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2.5 Statistical Analysis
Throughout the following chapters, data are presented as number (percentage) for 
categorical variables and median (90% range) for continuous variables. In all “Box 
and Whisker Plots”, boxes represent the median and interquartile values and open 
circles indicate outlying/extreme values.
Data on clinical characteristics and laboratory results were compared between 
different patient groups using the Chi-square test or Fisher’s exact test for categorical 
variables, and the Mann Whitney test or the Cuzick test for trend for continuous 
variables. Within-patient comparisons of different parameters, or of the same 
parameter measured at different time-points, were performed using the Wilcoxon 
signed-rank test. Spearman’s rank correlation was used to evaluate relationships 
between continuous variables assessed concurrently. All statistical computations were 
carried out using SPSS Version 14 (Chicago, Illinois, USA) and Stata-SE Version 8 
(Texas, USA).
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3.1 Introduction
Reports describing the clinical picture in adults with dengue have only recently started 
to emerge, and suggest that unusual complications with high mortality such as acute 
liver failure, encephalopathy, myocarditis and acute renal failure are more common in 
this group than in children [10,13]. In one study from Nicaragua signs of vascular 
leakage, shock and marked thrombocytopenia were seen less commonly with 
increasing age, although internal haemorrhage occurred more frequently in the adult 
subjects [14]. In a small prospective study from Sri Lanka, evidence of vascular 
leakage and shock were also seen more frequently in children compared to adults, 
although bleeding manifestations were similar [9], while in three small studies from 
Southeast Asia bleeding manifestations, thrombocytopenia and hepatic dysfunction 
were seen more commonly in young adults with the frequency of shock similar to the 
paediatric patient group [13,15,98]. In this chapter I will describe the patterns of 
disease, management strategies, and outcomes for patients recruited into the main 
adult cohort in comparison with those of paediatric cases recruited into the paediatric 
studies during the same calendar time at HTD. HTD is the main referral hospital for 
adults with dengue for southern Vietnam but receives few paediatric referrals. Since 
referred patients are likely to have more severe disease than direct admissions we 
considered these two groups separately and structured the comparisons between the 
age groups to take into account the route of admission.
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Secondly I will describe the pattern of liver involvement in the adult cohort in more 
detail -  in particular looking at liver involvement in relation to the severity of vascular 
leakage and of bleeding. Due to the infrequent development of hepatic complications 
in children in our setting we do not routinely assess liver function, and limits on the 
volume of blood taken from the children for research purposes did not allow 
comparable assessment in the paediatric cohort. One factor that may influence the 
pattern of disease seen in adults is the greater likelihood of underlying chronic 
diseases, potentially compounding the effects of the acute infection. Chronic viral 
hepatitis is common among adults in many tropical and sub-tropical countries where 
dengue is endemic, and it has been postulated that dengue infection occurring on a 
background of chronic HBV or HCV infection may result in more severe liver 
dysfunction and/or haemorrhage than is usual in non-infected individuals. However, 
the evidence to date is conflicting with two small studies indicating no effect 
[99,100], while one study suggests that concomitant HBV infection may result in 
greater hepatic dysfunction [101]. Therefore I also examined the question of whether 
concomitant infection with HBV or HCV influenced the overall severity of the 
clinical picture in this cohort.
3.2 Methods
Information relating to the general clinical, laboratory and statistical methods is 
presented in Chapter 2. A specific point for this chapter is that when comparing 
platelet counts between children and adults we used multiple linear regression to
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assess the effect of covariates including age-group (age < 15  years versus age > 15  
years, sex, infecting serotype (DENV 1 - 4 or unknown), and immune status (primary 
or secondary infection or unknown status).
3.3 Results
During the selected time-periods (September 2006 -  September 2008 for the ICUs 
and the calendar year 2007 for the infection wards) a total of 947 children and 738 
adults with suspected dengue were enroled into the paediatric and main adult cohorts. 
Among them, 881/947 (93%) children and 647/738 (88%) adults were confirmed to 
have dengue on one or more of the diagnostic assays. In the other patients, 33 children 
(3%) and 47 adults (6%) were classified as having OFI (5/47 adults were admitted 
briefly to the AICU for observation during the critical period); 12 children (1%) and 
31 adults (4%) had negative dengue diagnostics or an alternative diagnosis (e.g 
malaria, bacterial sepsis etc.). In the remaining 21 children (2%) and 13 adults (2%) 
the results of serological and virological diagnostics were inconclusive. Among all 
patients, 448/947 children (47%) and 295/738 adults (40%) attended for follow-up.
3.3.1 Comparison of the clinical picture between adults and children with dengue
Only patients with laboratory confirmed dengue were included in this comparison. 
The infecting serotype was identified in 450/881 (51%) children, and in 207/551 
(38%) adults in whom DENY RT-PCR was performed. Serotype distribution was 
similar in the two populations: DENV-1 was detected in 254/450 (56%) children and 
108/207 (52%) adults; DENV-2 in 102 children (23%) and 65 adults (31%); DENV-3
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in 93 children (21%) and 30 adults (14%); and DENV-4 in 3 children (1%) and 4 
adults (2%). Two children had mixed infections. Co-morbidities were uncommon, and 
were distributed across the severity groups; 1 child and 8 adults had a history of 
asthma, 2 children had epilepsy and one child had haemophilia, 2 adults had thyroid 
disease, one had diabetes mellitus and three each had valvular heart disease and 
hypertension. All patients with co-morbidities survived. Notably, all 3 pregnant adult 
females in the study developed DSS.
3.3.1.1 Clinical description of patients requiring intensive care
Between September 2006 and September 2008, we recruited 388 children admitted 
directly to PICU with suspected dengue and hypovolaemic shock (> 95% of all such 
cases) plus a further 19 children who were recruited into the study in the paediatric 
infection ward and subsequently transferred to PICU with clinical DSS (Figure 3-1). 
There were no external referrals from other facilities during the two-year period. Of 
the 407 children studied, 402 (99%) were confirmed to have dengue. Immune status 
could be reliably determined in 325/402 (81%) of cases, of whom 18 children with 
DSS (6%) had primary infections (DENV-1=13; DENV-2=1; unknown serotype=4).
During the same two-year period 341 adults admitted to AICU with suspected dengue 
were also recruited (90% of all suspected dengue admissions to AICU), of whom 315 
(92%) were subsequently confirmed to have dengue. Only 186/315 (59%) of the 
adults with confirmed dengue were admitted directly to HTD with the remaining 129 
(41%) being external referrals from other facilities. 110/315 (35%) of the adults
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studied in AICU had DSS (59 direct admissions and 51 external referrals), 94 (30%) 
experienced a variety of other serious complications (47 direct admissions and 47 
external referrals), and 111 (35%) were admitted for close observation (79 direct 
admissions, 31 external referrals, 1 internal referral) but ultimately recovered without 
developing any major complications (Figure 3-1). Immune status could be determined 
in 260/315 (83%) of the patients in AICU, only 16 of whom had primary disease, with 
only 1 case identified among the patients with shock.
Patients with DSS
Table 3-1 presents a summary of key clinical features, management, and basic 
laboratory findings, comparing children and adults admitted directly to the two ICUs. 
Over the two-year period almost 7 times as many children as adults were admitted 
directly with DSS. The median age for paediatric patients was 9 years. Most adults 
were in their twenties or early thirties with no patient older than 37 years. Timing of 
onset of shock was similar in the two groups. Vomiting, abdominal pain and headache 
were more common among adults at presentation (Chi square test, p = 0.003, p < 
0.001 and p < 0.001 respectively). All adults experienced some clinical bleeding, 
primarily mild/moderate mucosal bleeding, while one third of children had no 
bleeding and over 50% manifested only minor skin bleeding during the disease 
course. Eight children and 3 adults had severe bleeding, all in association with 
profound shock, and 5 children and 1 adult required whole blood/packed cells 
transfusion.
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Chapter 3 -  Clinical features o f dengue infection in adults and children
Initial shock severity was similar in terms of the proportion with no recordable blood 
pressure or with very narrow pulse pressure (< lOmmHg) at presentation. However 
adults experienced recurrent shock much less frequently than did children, indicated 
by the need for colloid resuscitation in only 8 (14%) adults as compared to 197 (49%) 
children (Chi square test, p < 0.001). Adults were usually successfully managed with 
smaller volumes of fluid than children. Approximately one third of all patients 
developed clinical pleural effusions or ascites, but only 3 (5%) of adults compared to 
79 (20%) of children required diuretics. Three children (2 prolonged shock and severe 
bleeding, 1 prolonged shock with encephalopathy) and 1 adult (prolonged shock with 
encephalopathy) died despite full supportive care. All others made a frill recovery.
Data for the 51 externally referred adults with DSS are also presented in Table 3-1 
and clearly demonstrate that these patients were more severely ill than those admitted 
directly to AICU. Almost 60% of this group experienced recurrent shock and 11 
patients (22%) developed severe bleeding. Clinical pleural effusions and ascites were 
common with 12/51 (24%) developing respiratory distress. Five patients required 
assisted ventilation (4 with fluid overload, and 1 with encephalopathy and 
pneumonia), while the remainder were managed successfully with oxygen and 
diuretics. Two patients had severe liver dysfunction demonstrated by jaundice and 
very high transaminase levels, and two developed acute renal failure. A total of 7/51 
(14%) of these externally referred adults became encephalopathic, 5 in association 
with severe bleeding. Four (8%) of the 51 patients died - 3 due to severe bleeding and
fluid overload and 1 due to encephalopathy.
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Patients with severe complications without shock
Among the 94 patients admitted to AICU without DSS but with other severe 
complications, the clinical pattern was similar among direct admissions and external 
referrals, although the latter group tended to be more severely ill. There were 28/47 
externally referred patients (60%) with severe bleeding (among them 4 cases 
associated with severe liver dysfunction, 2 cases with encephalopathy and intracranial 
bleeding demonstrated on CT scan, 1 case with a bleeding peptic ulcer, and the 
remaining 21 cases with no associated disorder detected), 14 patients (30%) with 
mucosal bleeding that settled without intervention, 2 patients with severe liver 
dysfunction without bleeding, and 1 case each with isolated encephalopathy, 
haemoglobinuria, and profound thrombocytopenia. Among the 47 direct admissions, 
there were 12 patients (26%) with severe bleeding (among them 2 cases with 
associated liver and renal failure, and 1 case with a bleeding peptic ulcer), 27 patients 
(57%) with mucosal bleeding that settled, 3 patients with syncope, 2 patients with 
haemoglobinuria and 1 case each with isolated encephalopathy, severe liver 
dysfunction without bleeding, and profound thrombocytopenia. One of the externally 
referred patients with acute liver failure and severe bleeding died, but the remaining 
patients recovered.
Patients admitted for observation
A total of 111 patients were admitted to AICU for close observation, of whom 64 
(58%) had transiently narrowed pulse pressure without evidence of impaired
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peripheral perfusion. None of these patients went on to develop clear signs of shock 
and all were discharged well without specific interventions other than maintenance 
fluid therapy. Compared to the adults managed on the infection wards, these patients 
had significantly lower platelet nadirs and greater overall haemoconcentration (data 
not shown). Although 270 children with suspected dengue were admitted to PICU for 
close observation during the same period, none developed shock or any other 
complications and thus were not recruited, as per the PICU research protocol.
3.3.1.2 Clinical description of patients managed throughout on the infection wards
During 2007 we recruited 559 children - approximately 25% of all children admitted 
to the paediatric infection wards with clinical dengue, as judged from the hospital’s 
electronic database - and 398 adults - approximately 10% of all adults admitted to the 
adult infection wards with clinical dengue (and approximately 50% of those eligible 
from the designated bays on the relevant infection wards). Of the 559 children, 498 
(89%) were confirmed to have dengue, with immune status determined in 419 (84%), 
130 primary and 289 secondary infections. Nineteen of these children (4%) developed 
DSS in hospital (see ICU section) and another 7 children were transferred to PICU for 
observation but did not develop shock. Of the 398 adults, 333 (84%) had dengue 
confirmed, among whom immune status was determined in 266 (80%), 30 primary 
and 236 secondary infections. Within the dengue-confirmed group 286 adults had 
been admitted directly to HTD while 47 were external referrals. Only 1 adult was
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transferred to AICU, a patient with known hyperthyroidism who developed rapid 
atrial fibrillation that responded to conventional treatment.
Table 3-2 presents the clinical features and basic laboratory findings, comparing the 
472 children and 285 adults admitted and managed throughout on the infection wards 
(hereafter referred to as uncomplicated dengue cases), with findings for the externally 
referred adults presented separately. Significantly more males than females were 
recruited in the paediatric ward. This was consistent with the observed male/female 
ratio observed among all admissions to that ward, but was not apparent in the 
male/female ratio for PICU admissions. Children were admitted to hospital 
approximately one day earlier than adults. However, adults were generally more 
symptomatic than children -  most notably 70% complained of muscle pain compared 
to only 19% of children (Chi square test, p < 0.001). Bleeding also occurred more 
frequently in adults. Almost half the children had no bleeding and minor mucosal 
bleeding was noted in only 10%, primarily epistaxis, compared to 46% of adults with 
mainly gum or minor upper gastrointestinal bleeding. In contrast more than 60% of 
children received some maintenance fluid therapy compared to 29% of the adults, 
either because of vomiting or high fever with inadequate oral intake.
67
Ta
bl
e 
3-
2:
 
Su
m
m
ar
y 
of 
key
 
cl
in
ic
al
 
fe
at
ur
es
, 
th
er
ap
eu
tic
 
in
te
rv
en
tio
ns
, 
an
d 
la
bo
ra
to
ry
 
fin
di
ng
s, 
co
m
pa
rin
g 
ch
ild
re
n 
an
d 
ad
ul
ts 
w
ith
 
un
co
m
pl
ic
at
ed
 
de
ng
ue
 
m
an
ag
ed
 
on 
the
 
in
fe
ct
io
n 
w
ar
ds
£  o
£  § II a 'v  a 
.S ts '5
A C S  S3
-a g  °  
Z  s
© 73
uu
0>
c*
*a
73a>
73«S
©
00a©73
73
©•+-»
©
ss
’-+JCS
ID
00
CN
II
a
53
73
<
<N
Tf
S3
©s*
2
2
On
CO
I
vo
CN
C O
i d
uo(N
vo
I
CN
' — <-
7f-
<!
£
o
o
©
V
o
o
o
V
N-
co
I
vo
CN
<N
vo7f
CN
co
vo
I
<N
**
S3
V
s
©u
S3
©
-*■»ct
73
©
£
©xnXo
u.o
'd
©
t:o&
©
©-M©
2
C3X
u
CN
7f
VO
C O
o
C O
uo
I
cs
C O
a©
<lT
o o
<
<+Ho
&
Q
■a 4H
CO 7 f OOn, Ons>—^ v«-»/
O ID o
VO ID On
CN CN 1
<u
.SP
aJPh
OV
S3•c3S^H
00
1
vo
Xt>0
33oL)
00
.9
ID
CN
cv
CO
ID
CN
VO
i n '
00
I
I&<©
ffi
S3
V
so*©
wjX3CM
o
&
*4Ho
s*
Q
z -s  OO VO 
VO (N VO
CO CO
CO
***
o
o
o
V
VO
vo
tj-
oo vo
CO T f
C" CN 
O  CO
a
G G
7f 7fvw/
vo ovr"H o
CN CN
VO7f
XS-t0)>©
00.a73
<D
JD
3
00.a
73
CDJ J
X
o
£
2  o
o p  e3 
S3 H
73
CD
3
.axCD
©73O
00
I
CO
ID
7f-O
I
w
ID
CO
ID
00
S3• rH
73©
(D
00
S'
73
£
c3.*3S^oo
OX
«4Ho
c?©X
oovo
aa 55  ^o
S73
'H-o
& s  g
0)
C*H©
£
a £
S £  O 73
P
-3c
a
£>
-mo
©
73<u
73cl
op00
a<u
73
73a>-Mcs
#w
" a
E
ow
G
P
-3
3
. w*m3Oh
**
*
*
tP
cn
vo
oo
o
V
OV
CN
3<u
. £oo
3
> ►—i
<D
C5
3
§
.S3
3
OO
I
vo
cnoo
00
I
7t^
vo
00
I
cn
vo
K
00
a
3^
a
3
u
o
X
I
©
3
E
a
3!Z3
CN
vd
vo
I
CN
On
cn
wn7f
<
£
On
cn
U~)
oo
oo‘
cn,
On
t J-Tf
CO
cn
CO
cn
00cn,
O n
cn7 -
H
O
X
x
3
SC+Ho
oo
00
<D
3
Ch
O
&
Q
H
0
K
a
1
X3
VO7}-
I
cn
oo
©
V
CN
cn
cn
r^-
cn
I
CN
<D
I£
O
H
Offi
<u
00
3
"S4)
OM
4>
3 .
3M
<U>
O
X
. 2*C
3
>
*3
O
' 3
o
oo.
4>-m
3
O
4 )
X,c/o
Pm
3
3cr
- 3
o
3
Cm
73
4 )
3
£
7 3
3
4>
3
00
3
4>
73
7 3
0)
to
O
E
£
o
o
3
3
3
7 3
3
7 3  4>
S  3
18 3  
3  ’C  
£  3  •3 > 
r 3  co
XI
o
3
4 )
<u
£
X
3
O
|
E3 
O 
o
M
3  c £
O Min in
S"“Cm ^
S g
o .ti 
W X
j3 £  
«  §
^ ’S
7 3
4>
a
<u
o
3
4>Ui
3
4>M
3M
b
o•M
3
XOu
7 3
3
3
3
cm
1/D
3
X
o
3
3
<£
E3
4 )
7 3
3
4 )
c m
4 )
7 3i
4 )
00<**
3 r -H
. o c n
’ o o
CO J O
s
X
3
7 3
a H
Q
t 3
H
o o
3
4>f f i
o 0 0
■M 3
M 3
, 0 X
* c o
c m H
H - >
m
<L>
4->
X
j 2
3
U
f f i
4>
0 0
<D 34 -^
c 3
&
3
3
. O
3
4 )
4 )
S—i
W1 % -> 4 )
1 3 c m
X B M
u M
o c 2
* 3
M
X
f l 3
O
4 )
>
O
3
|m
’ 3
o * < M
* * 4 )
* * Q
* * c a
3
. 2
cm
O n
3
. 2
cm
vo
3
c m
3
cm
3
cm
3
7 3
00
3
O n
VO
Chapter 3 -  Clinical features o f dengue infection in adults and children
3.3.1.3 Basic laboratory findings
Normal HCT values are age-dependent, but the median maximum values recorded 
during the acute illness were similar, indicating greater increases in children than 
adults. Percentage haemoconcentration was also greater in children than adults in both 
the DSS and the uncomplicated dengue groups (both p < 0.001, Mann Whitney test), 
and consequently the proportion of children with > 20% haemoconcentration was also 
greater than among the adults (Chi square test, both p < 0.001). The median day of 
illness on which the maximum HCT occurred was slightly later (day 6) in the 
uncomplicated dengue patients than those with DSS (day 5) (Tables 3-1 and 3-2).
The platelet nadir occurred on day 6 of illness in both age-groups, with levels 
generally lower in those with shock than uncomplicated dengue (Figure 3-2). Only 8 
adults with shock - 4 with severe bleeding, and 4 with counts below 20 x 109/L who 
required an invasive procedure - and a further 13 adults with severe bleeding without 
shock received platelet transfusions in addition to other blood products. No paediatric 
patient received a platelet transfusion. Considering patients directly admitted with 
shock, daily platelet counts were consistently lower among adults than children 
(Mann Whitney test, p<0.001 for all daily comparisons between days 4 - 8). Similarly 
among direct admissions with uncomplicated dengue, thrombocytopenia was more 
severe in adults than children between days 2 - 10 of illness and also at the follow-up 
visit (Mann Whitney test, all p<0.01) (Figure 3-2). Multiple linear regression 
indicated that serotype and sex had no significant effects on the platelet nadir (p=0.53 
and 0.67 respectively for patients with uncomplicated dengue; p=0.12 and 0.25
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respectively for patients with shock), but that there was an association with immune 
status i.e. secondary infection was an independent predictor of a lower platelet nadir 
(estimate -22.0 x 109/L (95%CI: -30.6 to -13.4), p<0.001 in the uncomplicated 
dengue group, and -13.2 x 109/L (95% Cl: -23.8 to -2.7), p=0.01 in patients with 
shock). In addition, age-group had a pronounced effect on the platelet nadir (estimated 
effect of age > 15 years was -35.5 x 109/L (95% Cl: -43.0 to -27.9), p<0.001 in 
patients with uncomplicated dengue, and -6.7 x 109/L (95% Cl: -13.2 to -0.2), 
p=0.04 in patients with shock). Notably, age also significantly affected the platelet 
count at follow-up in the uncomplicated dengue group, with a larger effect size 
compared to that observed during the acute illness; the estimated effect of age > 15  
years (assessed by multiple linear regression adjusted for serotype and immune status) 
on follow-up platelet values was -41.7 x 109/L (95% Cl: -64.1 to -19.4), p<0.001. 
This relationship was not apparent for follow-up platelet values in the DSS group 
(estimated effect of age >15 years -6.5 x 109/L (95% Cl: -40.1 to 27.2), p=0.7).
Platelet counts significantly correlated with vascular leakage severity in adults during 
the critical and convalescent periods (Mann Whitney test, both p < 0.001), and also 
with bleeding severity in the early febrile (Cuzick test for trend, p < 0.05), critical and 
convalescent periods (Cuzick test for trend, both p < 0.01) (Figure 3-3). At follow-up, 
platelet counts were significant higher in adults with shock compared to those without 
shock (Mann Whitney test, p < 0.05) (Figure 3-3). Similar patterns were seen in the 
paediatric cohort except that the platelet counts were similar in the groups with and 
without shock at the follow-up visit (data not shown).
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Chapter 3 -  Clinical features o f dengue infection in adults and children
3.3.2 Liver involvement associated with dengue infection in adults
This section focuses on adults with confirmed dengue in comparison with OFI 
patients. Among the dengue patients, hepatomegaly was seen more commonly in 
patients with shock (83/110 patients, 75%) compared to those without shock (142/536 
patients, 26%) (Chi square test, p < 0.001). Visible jaundice was noted in only 11/647 
(< 2%) dengue patients (9 without shock and 2 with DSS), of whom 8 also 
experienced severe bleeding. All these patients met the criteria for severe liver 
dysfunction, and five of them, none of whom had shock, developed acute liver failure 
and severe coagulopathy. One patient in this group died. Only 5/47 (11%) OFI 
patients had hepatomegaly, and none developed jaundice.
Jaundice appeared relatively late in the dengue patients, commonly during the second 
week of illness several days after the expected time for shock (median (range) day of 
onset 7 (6 - 12)), and was minor in all cases except those with acute liver failure. The 
infecting serotype, DENV-2, was identified in only one case with severe liver 
dysfunction. Information on ingestion of potentially hepatotoxic medications was 
limited by the fact that most patients did not know what they had been prescribed 
before hospital admission. However, more than 90% of patients in the study admitted 
taking standard doses of paracetamol for symptomatic relief, with the pattern of 
ingestion similar in those with and without severe liver dysfunction. Although I 
attempted to gather information on prior alcohol consumption the response rate was 
poor and the data collected was felt to be unreliable, precluding analysis.
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3.3.2.1 Disturbances in liver function tests and associations with disease severity 
and coagulopathy
Bilirubin levels fell within the normal range for almost all patients except those with
visible jaundice. Results of the serial transaminase levels are shown in Figure 3-4,
presented according to the severity of vascular leakage, and grouped according to
timing during the evolution of the illness. Considering all dengue patients, only
22/647 (3%) had normal aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) levels (below or equal to 40 IU/L) throughout the course of
their illness, compared to 23/47 (49%) of the OFI patients. In the dengue group the
AST and ALT levels began to increase slightly in the early febrile period (median
(90% range) of 43 (18 - 314) for AST and 40 (14 - 236) IU/L for ALT levels,
compared to 24 (13 - 68) for AST and 32 (13 - 101) IU/L for ALT at follow-up,
Wilcoxon signed-rank test, p < 0.001 for AST and p = 0.02 for ALT). Both enzyme
levels increased significantly in the critical period (107 (30 - 482) for AST and 83
(22- 422) IU/L for ALT), and reached peak concentrations (138 (44 - 545) for AST
and 136 (30 - 590) IU/L for ALT) during the convalescent period (Wilcoxon signed-
rank test, all p < 0.001 for comparisons of both critical and convalescent values with
follow-up values and both p < 0.01 for comparisons of critical values with
convalescent values). The highest enzyme levels were recorded in patients with severe
liver dysfunction (median (90% range) of 1663 (320 - 8680) IU/L for maximum AST
levels during the disease course and 971 (334 - 9917) IU/L for maximum ALT
levels). Levels had returned to the expected normal range at the follow-up visit
(around 3 - 4  weeks after onset of illness) in 203 (88%) for AST and 145 (63%) for
ALT of the 231 dengue patients reviewed. ALT levels were significantly higher than
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AST levels in OFI patients in the critical and convalescent periods (Wilcoxon signed- 
rank test, both p < 0.05). In contrast, AST levels were consistently higher than ALT 
levels in the critical and convalescent periods in the dengue patients (Wilcoxon 
signed-rank test, both p < 0.01).
In terms of correlation between transaminase levels and markers of disease severity, 
during the critical period both AST and ALT levels were significantly higher in the 
dengue patients who experienced shock compared to those without shock (Mann 
Whitney test, both p < 0.01). This association was still apparent during the 
convalescent period for AST (Mann Whitney test, p = 0.02), but ALT levels were 
similar in the two groups at this time (Figure 3-4). In addition, the AST and ALT 
levels of the dengue patients correlated significantly with bleeding severity in the 
critical and convalescent periods (Cuzick test for trend, all p < 0.001, data not shown). 
We also looked for correlations between transaminase levels with results of 
coagulation tests recorded at the same time in the critical period: among all adults 
with dengue, both liver enzymes demonstrated weak or moderate negative 
correlations with the lowest platelet count (Spearman correlation of -0.32 for AST and 
-0.26 for ALT, both p < 0.001, n = 584); among patients who had coagulation tests 
performed, both liver enzymes demonstrated weak or moderate positive correlations 
with the APTT (Spearman correlation of 0.31 for AST and 0.23 for ALT, both p < 
0.05, n = 124) and moderate negative correlations with plasma fibrinogen level 
(Spearman correlation of -0.37 for AST and -0.3 for ALT, both p < 0.01, n = 124). 
However, the PT showed no significant associations with transaminase levels 
(Spearman correlation of 0.02 for AST and -0.11 for ALT, both p > 0.2, n = 124) 
(data not shown).
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Chapter 3 -  Clinical features o f dengue infection in adults and children
3.3.2.2 Effect of chronic HBV or HCV co-infection on bleeding severity and 
laboratoiy results
Anti-HCV serology was positive in only 3 (2 dengue patients and 1 OFI patient) 
among the 207 patients tested. Evidence for prior exposure to HBV (antiHBc 
positive) was found in 344 of 692 patients tested (50%), with evidence for chronic 
HBV infection (antiHBc positive, HBsAg positive and antiHBc IgM negative) 
detected in 69/620 (11%) dengue patients and 9/47 (19%) OFI patients. Acute HBV 
infection (positive antiHBc IgM) was not found in any patient. In the dengue group 
ALT levels in the critical period were modestly but significantly higher in patients 
with chronic HBV co-infection than in patients without co-infection (Mann Whitney 
test, p = 0.001). A small increase in AST levels was also observed in the critical 
period but this was not statistically significant. No association was demonstrated 
between AST or ALT levels and HBV co-infection by the convalescent period (Table 
3-3). In addition HBV infection had no effect on bleeding severity, vascular leakage 
severity or development of shock, severity of thrombocytopenia, or on any of the 
coagulation screening tests in the dengue patients. HBV infection was noted in only 
one of the eleven patients with severe liver dysfunction, and in none of those with 
acute liver failure.
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Table 3-3: Effect of chronic HBV co-infection on bleeding severity and 
transaminase levels in 620 adults with dengue
Characteristic
Chronic HBV 
co-infection
(n = 69)
No evidence for 
HBV infection
(n = 551)
P value3
Severe bleeding 7(10) 43 (8) 0.5
Mucosal bleeding or any 
severe bleeding 46 (67) 314(57) 0.12
AST in critical period 122 (28 -  548)
105
(30-483) 0.06
ALT in critical periodb 118 (29 -  520)
80
(22-385) 0.001
AST in convalescent period0 152(58-443)
137 
(41 -563) 0.67
ALT in convalescent period0 144 (50 -  637)
134 
(29 -  575) 0.19
a Chi square or Fisher’s Exact test, or Mann-Whitney test were used as appropriate.
b No of patients with and without chronic HBV co-infection in critical period are 62, 500 
respectively
c Numbers of patient with and without chronic HBV co-infection in convalescent period are 
56, 419 respectively
3.4 Discussion
3.4.1 Comparison of clinical picture between adults and children with dengue
The availability of detailed prospectively-collected observational data on a large 
number of dengue patients admitted to a single institution in an endemic region 
permitted this examination of the clinical patterns of dengue disease by age. We
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found that although the overall clinical picture was similar in children and adults 
some clear differences were apparent, particularly in the pattern of complications 
seen. Admission with shock and development of recurrent shock were more common 
in children than adults, and plasma leakage was more profound. In contrast bleeding 
manifestations and organ involvement were more common and more severe in adults. 
Thrombocytopenia was also more severe in adults, but this may reflect similar 
disease-associated effects superimposed on intrinsically lower normal platelet values 
in adults compared to children.
Health-seeking behavior and local admission policies and referral systems may 
influence observed disease patterns, particularly in a hospitalized population. For 
example the male excess among children with uncomplicated dengue has been 
documented previously and may reflect parental health-seeking behavior [8,102]. 
HTD admits around 7,000 - 10,000 patients with suspected dengue annually. 
Although it functions as the main provider of inpatient care for local adults with 
dengue as well as being a referral centre for severe adult disease, local children may 
be taken preferentially to one of two paediatric hospitals in the city and HTD receives 
few regional paediatric referrals. We considered that referred patients were more 
likely to have severe disease than direct admissions, and in fact we confirmed that 
adults transferred from other hospitals were more severe than those admitted directly 
to HTD (Table 3-1). However since we had focused the comparative statistical 
analysis only on direct admissions from the local area, we consider that the main
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conclusions about the different disease patterns seen in children and adults are valid 
and representative of the patterns of symptomatic disease by age in this environment.
The findings support the generally accepted view that severe vascular leakage is more 
common in children [14,103]. Age is known to influence intrinsic vascular 
permeability, with children demonstrating a lower threshold for leakage than adults 
[104]. Similarly, homeostatic mechanisms aimed at minimizing cardiovascular 
decompensation in the face of increased permeability are less well developed in 
children. However it is important to note that the population affected by dengue in 
Vietnam, a hyper-endemic country, is relatively young - the oldest patient in the study 
was aged 57 years and the oldest DSS case, 37 years. Secondary infection is well 
recognised as a risk factor for severe disease; 6% of the paediatric shock cases had 
primary infections compared to 30% of the uncomplicated paediatric cases, while 
only 6% of adults overall had primary disease with a single patient (aged 18 years) 
identified among the shock cases. Reports from Taiwan and Singapore, where 
endemicity is lower than Vietnam and secondary infections likely to occur later in 
life, indicate that infections occurring in elderly patients with co-morbidities are at 
greater risk for severe complications and death [105,106].
Skin and mild to moderate mucosal bleeding were significantly more common in 
adults, and severe bleeding in the absence of DSS occurred only in adults. Although 
we cannot exclude the possibility that some local children with severe bleeding 
without shock were admitted to one of the two major local paediatric hospitals,
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informal communication with both centres indicates this presentation to be rare. Since
coagulation tests were not performed systematically in the children involved in this
analysis, no direct comparisons were possible. However, thrombocytopenia was more
marked in adults than children, with significantly lower platelet counts documented
throughout the evolution of the disease and with clear associations with the severity of
leakage and bleeding. The multiple linear analysis indicated that this effect cannot be
explained solely by the fact that adults had more secondary infections than children -
adult age-group was an independent predictor for lower platelet counts for both
severity groups during the acute illness and for the uncomplicated dengue patients at
follow-up. The absence of an apparent effect at follow-up in the DSS patients may be
explained by differences in the timing of these visits. Most adults attended for review
around 2 weeks after discharge, at a time when rebound thrombocytosis was likely
still to be a factor, while no children returned for review until 3-4 weeks after
discharge when this effect should have settled. Rebound thrombocytosis is normally
proportionate to the severity of preceding thrombocytopenia and may have
confounded the age effect in the DSS patients (Figure 3-3). Few data are available on
platelet changes with age, but one European study that examined platelet counts in
500 healthy subjects also demonstrated a progressive decline in platelet numbers
during childhood, leveling off at 18 years [107]. It is therefore likely that the higher
frequency and greater severity of bleeding manifestations in adults with dengue
reflects the combined effects of several factors: intrinsically lower platelet counts in
adults; a greater likelihood for adults in endemic areas to experience secondary
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dengue infections which are associated with more severe thrombocytopenia than 
primary infections; and a higher background rate of underlying diseases such as peptic 
ulcer disease that may result in compromised tissue integrity [108].
We also found that children were generally less symptomatic than adults in the febrile 
phase of uncomplicated dengue, although they were more than twice as likely to 
receive maintenance intravenous fluid therapy. Comparisons of management 
strategies between the groups are complicated by the fact that both general and 
dengue-specific fluid management guidelines are tailored to expected age-related 
requirements. However the favourable outcome in most cases, together with the fact 
that significantly greater haemoconcentration was demonstrated in the children 
despite their receiving considerably more fluid therapy overall than the adults, 
indicates that the interventions were likely proportionate to need. Over the years 
considerable experience has accumulated regarding fluid management of children 
with dengue, but as epidemiological patterns begin to change and more adults present 
with severe and complicated disease, it is crucial that suitable management algorithms 
are developed that are relevant to the age-groups at risk. Additionally, given that 
profound but frequently asymptomatic thrombocytopenia is almost universal in adults 
with dengue, but also that even among young and otherwise healthy adults severe 
bleeding may occur, the lack of practical guidelines on the use of blood products 
needs to be addressed. For example, prophylactic platelet transfusions are becoming 
almost routine in some dengue-endemic countries, using arbitrary thresholds without
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evidence of benefit [109,110]. In Vietnam, given the lack of evidence in this area, 
prophylactic platelet transfusions are not advocated in the national guidelines. Current 
Vietnamese MOH recommendations are that in the absence of active bleeding platelet 
transfusions should be considered only when the platelet count falls below 5 x 109/L. 
However it is well known that individual clinicians, particularly those working in 
private hospitals, do give prophylactic platelets at higher thresholds up to around 20 x 
109/L. A recent survey conducted from OUCRU to assess approaches to the use of 
platelets in dengue received responses from 306 physicians in 20 different countries; 
the heterogeneity of the responses highlighted considerable variation in clinical 
practice both within and between countries [111]. In view of the clinical risks 
associated with platelet transfusions and the financial cost of such practice it is 
essential that formal research studies are carried out to provide an evidence base from 
which to develop clinical practice guidelines for use in dengue-endemic areas in the 
future.
3.4.2 Liver involvement associated with dengue infection in adults
The main finding was that mild to moderate hepatic inflammation, assessed by serial 
measurements of liver enzyme levels, was apparent in almost all dengue patients and 
correlated with other measures of severity, although the most abnormal results were 
noted rather later than the generally accepted critical period for other complications.
Transaminase levels began to increase from an early stage (day 1 - 3 of illness) and 
peaked during the second week of illness. Severe liver dysfunction was rare, but also
84
Chapter 3 -  Clinical features o f dengue infection in adults and children
commonly occurred during the second week of illness. By follow-up, AST levels had
returned to normal in the majority of cases, but ALT levels remained slightly
increased above the normal range in approximately one-third of patients. This general
pattern, with AST increasing more quickly and peaking at a higher level, and then
reverting to normal more quickly than ALT levels, is unusual and differs from that
commonly seen during acute hepatitis caused by hepatitis viruses [112], but is similar
to observations in previous studies of dengue in both children and adults
[99,100,113]. In addition, the effect of chronic HBV co-infection was primarily
apparent on ALT levels. Although these results indicate that most adults with dengue
infection have some degree of hepatic involvement, an additional non-hepatic source
of AST could explain the pattern observed; ALT is primarily associated with
hepatocytes, with minimal activity in cardiac and skeletal muscle, while AST is
present in red blood cells, cardiac and skeletal muscle, and kidney and brain tissue,
and is often elevated due to damage to those sources as well as in response to hepatic
damage [112]. Given the prominence of musculoskeletal symptoms among adults
with dengue, skeletal muscle injury could contribute to the elevation in AST levels.
The plasma half-life of AST is shorter than that of ALT [112], but it is possible that
the slower improvement in ALT levels simply reflects slower evolution of the hepatic
disease than of the musculoskeletal problems. We was unable to investigate specific
muscle enzymes or isoforms in this study, but creatine kinase levels are known to be
elevated during the acute phase of dengue infection [114]. In combination with other
simple laboratory tests transaminase levels, particularly AST levels, have been
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suggested as a potential marker to help differentiate dengue from other viral infections 
during the early febrile phase [115]. However, mild to moderate increases in 
transaminase levels, with AST higher than ALT levels, are a non-specific finding that 
may be observed in a number of other infections such as typhoid fever and malaria 
[116,117], as well as in alcohol related hepatitis [112].
In agreement with previous smaller studies, we found associations between 
transaminase levels and increasing severity of vascular leakage as well as with 
bleeding severity [99,100,113,118]. Acute liver failure developed in only a small 
number of cases, none of whom had severe vascular leakage. Although liver 
involvement might be expected to contribute to derangements in haemostatic 
parameters, we only found prolonged PT values in the patients with liver failure. In 
most other patients PT values fell within the normal range and were similar to the 
values seen in the OFI group; also we only demonstrated a weak correlation between 
PT and transaminase levels during the convalescent period, suggesting that liver 
synthetic function in terms of coagulation factor production was generally well 
compensated.
The pathogenesis of liver involvement during dengue infections is still poorly 
understood [119]. Potential mechanisms of hepatic injury involve a variety of 
potential insults including direct effects of the virus or host immune response on liver 
cells, circulatory compromise and/or hypoxia due to hypotension or localized vascular 
leakage inside the liver capsule, hepatotoxic effects of drugs such as acetaminophen
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or traditional herbal remedies, and tissue tropism of particular viral serotypes or 
genotypes. Given the fact that many organ systems are deranged by the time a patient 
dies, histopathological findings from autopsy studies are of limited value in trying to 
clarify primary disease mechanisms, and unfortunately suitable biopsy material is 
rarely available from less severe cases. The magnitude and evolution of the liver 
enzyme changes demonstrated in this study, and the relationships that we observed 
with other markers of disease severity, favour an adverse effect of immune 
dysregulation over a direct viral effect as the likely primary mechanism responsible 
for the hepatic dysfunction in the majority of patients. Dengue virus is rapidly cleared 
from plasma during the first few days of symptoms and viral RNA is rarely detectable 
after the first week of illness [41,120]; a direct viral effect might be expected to be 
maximal early in the infection coinciding with peak viremia although it is plausible 
that virus remains sequestered in the liver for some time after clearance from plasma. 
However, the host immune response is well established by the time the critical phase 
(day 4 - 6 of illness) is reached, particularly in secondary infections, and is generally 
considered to be a crucial factor in the development of other complications such as 
shock and thrombocytopenia [50,60].
Regarding the effects of concomitant infection with other hepatitis viruses common in 
Asia, we found a significant increase in ALT levels in dengue patients with chronic 
HBV infection compared to those without infection. The effect was minor however, 
and did not affect coagulation parameters or impact bleeding severity or clinical signs
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of liver disease. In the past, several small studies have shown no effect of HBV 
infection on acute dengue morbidity [99,100], but our findings are in agreement with 
a recent study in which some 400 patients with DEN-1 infection were studied with 
slightly greater increases in ALT levels found among the patients with HBV co- 
infection [101]. We found no clinically significant effects in this study, but the 
possibility that repeated dengue infections may alter the rate of progression of the 
HBV infection needs to be considered. Very few patients with HCV infection were 
identified and we were unable to assess the effects of co-infection with this virus.
3.4.3 Summary
In summary, this comparison of the clinical features of a large number of adults and 
children with dengue demonstrates that the complications experienced by the two 
groups tend to reflect age-related physiological norms. Thus children, who have 
intrinsically higher microvascular permeability tend to develop vascular leakage and 
DSS, while adults, with intrinsically lower platelet numbers and a greater likelihood 
of having concomitant disorders that compromise mucosal integrity or influence 
specific organ function, tend to experience bleeding complications or severe organ 
impairment. Secondly it is clear that liver involvement, demonstrated by increases in 
transaminases levels, occurs in almost all adults with dengue and correlates with 
disease severity in terms of vascular leakage and bleeding. In most cases the 
involvement is mild and has little effect on coagulation parameters. Severe liver 
dysfunction and acute liver failure develop in only a small proportion of patients
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(usually without evidence of vascular leakage severe enough to cause shock) but are 
often associated with severe bleeding. Chronic hepatitis B co-infection was associated 
with modestly but significantly increased levels of ALT, but did not otherwise impact 
the clinical picture.
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4.1 Introduction
As described in section 1.11 research to date suggests the increase in APTT seen 
during dengue infections could be due to one or both of the following mechanisms: a) 
a decrease in plasma coagulation factor levels following leakage from the 
intravascular to the interstitial compartment or b) the presence of a circulating 
anticoagulant such as the endothelial GAG, heparan sulfate.
In this chapter I will describe work done to examine these possibilities using plasma 
samples collected from the main adult cohort.
4.2 Methods
4.2.1 Patients and clinical methods
For the immediate 50/50 mixing studies and the HS measurements described below, 
we used serial citrated plasma samples from the first 100 adults recruited in AICU and 
the first 100 adults recruited on the infection wards. Unfortunately after completion of 
these studies there was no citrated plasma, and very little EDTA plasma, left from 
these patients, so for the remaining heparinase experiments we used selected samples 
from other confirmed dengue patients in the main adult cohort. General methodology 
relating to the main adult cohort is described in Chapter 2.
To assess differences in HS levels between dengue and other infectious diseases we 
used residual plasma from other clinical studies carried out at OUCRU in recent 
years, including studies on severe malaria, Japanese encephalitis, bacterial meningitis,
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typhoid fever and tetanus. In each study the diagnosis was confirmed by conventional 
diagnostic tests according to the particular disease. Residual plasma from 20-30 
patients in each disease group, that had been obtained within the first week of illness 
and stored frozen, was used.
4.2.2 Specific laboratoiy investigations
4.2.2.1 Immediate APTT 50/50 mixing studies 
Standard APTT measurements:
The APTT test involves recalcification of citrated plasma in the presence of a 
standardized amount of cephalin and a factor XII activator (kaolin) to induce clot 
formation. We used standard reagents (CK Prest) and an ST4 Hemostasis Analyser 
from Stago, France. Following their instructions the cephalin/kaolin mixture and a 
high concentration calcium chloride (CaC12) solution (0.025mol/L) were first 
incubated separately at 37°C for at least 10 minutes. Then 50 pL of the test plasma 
and 50 pL of the cephalin/kaolin mixture were incubated together in a cuvette at 37°C 
for 3 minutes. Then 50 pL of the pre-incubated CaC12 solution was rapidly added to 
the mixture and the timer started simultaneously, in order to record the time to clot 
formation in seconds.
APTT Mixing studies:
Mixing studies can be helpful to investigate the cause of a prolonged APTT result 
(either coagulation factor deficiency or presence of a circulating anticoagulant). The
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study is performed by mixing the patient plasma sample with normal pooled plasma 
(NPP) and then repeating the APTT test. The principle of this mixing test relies on the 
fact that if the result corrects to normal a deficiency of one or more coagulation 
factors is suspected, whereas if the result remains abnormal a circulating 
anticoagulant is likely to be present [63,121]. The ratio of patient plasma sample to 
NPP is usually either 1:1 (APTT 50/50 Mix) or 4:1 (APTT 80/20 Mix). The APTT 
80/20 Mix allows for partial correction of coagulation factor deficiencies and is 
recommended if a mild anticoagulant is suspected because the APTT 50/50 Mix (with 
full correction of coagulation factor deficiencies) can mask the presence of such 
anticoagulants. In addition, the APTT Mix can be measured either immediately after 
adding NPP into the test sample (Immediate APTT Mix) or delayed for one to two 
hours to allow incubation of the mixture at 37°C (Incubated APTT Mix), when the 
presence of a time dependent anticoagulant is suspected [122]. The immediate APTT 
50/50 mixing test is the most commonly used and we chose to use this test for our 
initial investigations -  thus we added 25 pL NPP to 25pL patient plasma, then 
measured the APTT of this mixture immediately with the same procedure as 
described above.
4.2.2.2 Heparan sulfate measurements
We used commercial Heparan Sulfate ELISA Kits (Seikagaku, Japan) to measure HS 
levels in either EDTA or citrated plasma samples from the above selected patient 
groups, following the manufacturer’s instructions. Preliminary investigations
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comparing the results from 10 EDTA and 10 citrated plasma samples taken from the 
same patient during the same venepuncture revealed that percentage differences in HS 
levels between these two types of specimen were within 10% (data not shown).
4.2.2.3 Heparinase experiments
Having established the presence of high HS levels in the dengue patients (see results 
section 4.3.3.2), we performed several experiments using heparinase enzymes to 
investigate whether the HS functions as a circulating anticoagulant -  i.e. we wished to 
degrade any HS present using specific enzymes and then to determine whether the 
increase in APTT reversed after this treatment. We used recombinant enzymes from 
Ibex Technologies Inc (Quebec, Canada) - heparinase III that exclusively degrades 
HS but not unfractionated heparin or low molecular weight heparins, and heparinase I 
that mainly degrades heparin, and HS to a lesser extent. Heparinase III is the most 
specific enzyme for degrading HS but since the fractions left may retain some 
anticoagulant properties, after discussion with experts in the field we elected to carry 
out preliminary experiments using combinations of the two enzymes in healthy 
plasma spiked with HS, in order to establish the most suitable protocol to use on the 
precious remaining patient samples. Thus we first investigated different cocktails of 
the heparinase enzymes under different experimental conditions for the incubation of 
plasma samples with heparinases. Experimental conditions applied for enzyme 
incubation such as temperature, pH and length of incubation as well as calcium 
concentration in the mixture of samples and enzymes are all parameters that have the
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potential to interfere with APTT results irrespective of any enzyme effect. Fortunately 
the enzymes work well over a wide range of temperature (20 -  37°C) and pH (5.5 -  9) 
so we maintained standard conditions - room temperature (RT) and physiological pH, 
for these parameters. However, it was necessary to investigate the effects of the 
inherent time delay required to incubate plasma samples with the heparinase enzymes 
- the time delay allows the enzymes time to be effective but it should not be more than 
one or two hours to prevent the gradual loss of coagulation factors after this time.
94-Secondly, Ca is a co-factor for heparinase enzyme activity, with ideal 
concentrations said to be between 2.5 and 5mmol/L -  although this concentration is 
much lower than the concentration used to initiate clot formation in the standard 
APTT test, even small amounts of Ca may shorten the APTT by triggering the onset 
of clot formation early. Several experiments are described below in which we 
assessed the effects of time delays and Ca2+ concentrations, in the end choosing the 
enzyme cocktail and experimental conditions that were most effective for degrading 
HS but had the least intrinsic effect on APTT results, for the main study.
4.3 Results
4.3.1 Patient information
Among the 200 adults with suspected dengue included in this section of the work, 
dengue was confirmed in 165 (83%) patients (38 with DSS and 127 without shock) 
while 21 (11%) patients were classified as having OFI. An alternative diagnosis was 
confirmed or suspected in 4 (2%) patients, all o f whom had negative dengue
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diagnostics. In the remaining 10 (5%) patients the results of serological and 
virological diagnostics were inconclusive.
4.3.2 Screening coagulation tests
4.3.2.1 Prothrombin time
In general, PT values were only marginally affected and improved during the 
evolution of the illness in both OFI and dengue groups. During the early febrile 
period, PT values were slightly prolonged but the number of patients assessed at this 
time was small (and no patients with shock were included until later). In the critical 
period PT was slightly increased in both dengue groups (Wilcoxon signed rank test, 
both p < 0.01, Table 4-1) but only the results of patients with shock were significantly 
different from those seen in the OFI group (Mann Whitney test, p = 0.04). There was 
a significant association between PT and vascular leakage severity in the critical 
period (Mann Whitney test, p = 0.03). Also, there were significant associations 
between PT and bleeding severity in the critical (Cuzick test for trend, p = 0.04) and 
the convalescent periods (Cuzick test for trend, p = 0.02) (data not shown).
4.3.2.2 Activated partial thromboplastin time
The APTT was slightly prolonged in the early febrile period, increased further during 
the critical period and remained slightly prolonged in the convalescent period (Table 
4-1). The APTT results significantly correlated with vascular leakage severity during 
the critical period (Mann Whitney test, p < 0.001) and also during convalescent period
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(Mann Whitney test, p = 0.02). In general the APTT was more prolonged in those 
with more severe bleeding during the critical period, but no statistically significant 
relationship was found (Cuzick test for trend, p = 0.07) (data not shown).
One possible explanation for the increase in APTT that has not been considered 
previously is that it may be artifactually prolonged due to the haemoconcentration that 
is a typical feature of many dengue infections. Samples with high HCT values have 
relatively higher citrate concentrations in the plasma in the collection tubes, and this is 
recognized to increase both PT and APTT values [123]. Typically however, 
significant prolongation in APTT but not in PT is seen during dengue infections - i.e. 
as described above in this study and in previous work in children [86,90]. It is 
generally suggested that if the HCT value of a blood sample is more than 55%, then 
both the PT and APTT results may be significantly inaccurate and adjustment of the 
blood to citrate ratio is recommended [123]. Therefore we repeated the analysis only 
including APTT results for which the corresponding HCT value was <55% and found 
the same pattern for changes in APTT as we had demonstrated when including all 
APTT results (Table 4-2). The significant correlations with vascular leakage severity 
during the critical (Mann Whitney test, p = 0.002) and convalescent periods (Mann 
Whitney test, p = 0.03) remained apparent and we do not believe that 
haemoconcentration contributed to the overall effects observed.
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Table 4-2: Serial APTT results for the dengue patients, including only results for 
samples with a corresponding HCT value < 55%
Day 1-3 Day 4-6 Day 7-10 FU
OFI
34.8
(32-47.5)
(n= ll)
35*
(28-40.8)
(n=T9)
33.7
(28.5-39.9)
(n=8)
33.8
(31.8-38.2)
(n=10)
Dengue without shock
40.8*
(34.5 -  50) 
(ii=14)
44 _ j ***
(33.9-62.9) 
(n= 97)
41.6***
(31.1-57.4)
(n=89)
33.3
(27.9-51.8) 
(n= 70)
DSS
48.4**
(39.3-92.6)
(n=21)
(32.6 -120) 
(n=35)
34.5
(28.1 - 66.6)
(n=27)
- Data are expressed as median (90% range).
- The total number of patients included in each group for each time period is indicated.
- The Wilcoxon signed rank test was used to compare the results in each time period with the 
corresponding results at follow up (here taken to represent the normal value for that 
individual). *: p < 0.05, **: p < 0.01, ***: p < 0.001.
4.3.2.3 Plasma fibrinogen levels
Plasma fibrinogen levels were slightly increased in the early febrile period in both 
OFI and dengue patients without shock (Wilcoxon signed rank test, both p < 0.05), 
reflecting the fact that fibrinogen is an acute phase protein. Subsequently fibrinogen 
levels were significantly lower in dengue patients both with and without shock during 
the critical period (Wilcoxon signed rank test, both p < 0.01) and in dengue patients 
without shock during the convalescent period (Wilcoxon signed rank test, p < 0 .01) 
(Table 4-1). There was a significant inverse association between fibrinogen levels and 
vascular leakage severity in the critical and convalescent periods (Mann Whitney test,
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both p <0.01). Also, fibrinogen levels significantly correlated with bleeding severity 
in the critical period (Cuzick test for trend, p = 0.007) (data not shown).
4.3.2.4 D-Dimer
D-Dimers were either negative or weakly positive in most patients. The percentages 
for each category were similar between the OFI and dengue patients (Table 4-1). 
There was no association between D-Dimers and either vascular leakage or bleeding 
severity (Chi square test, all p > 0.1).
4.3.2.5 Summary of screening coagulation tests
Similar to the results of previous work in children [86,90], the pattern of coagulopathy 
seen in adults with dengue included mild to moderate increases in the APTT with 
reduced plasma fibrinogen levels, but only marginal increases in the PT and generally 
negative D-Dimers. This pattern would be unusual for DIC since there was no real 
evidence of pro-coagulant activation. Therefore the mechanisms underlying these 
typical coagulation disturbances need to be explored further.
4.3.3 Specialized investigations to explore the increase in APTT
4.3.3.1 Immediate APTT 50/50 mixing investigations
Following the addition of NPP, there was considerable improvement in the APTT -  
the median APTT returned to around 34 seconds or lower (Figure 4-1), indicating 
likely coagulation factor deficiency. However, there was a residual small but 
significant increase in the APTT in the dengue patient groups compared to OFI in the
100
Chapter 4 - Exploring the mechanisms responsible for the increase in APTT 
critical and convalescent periods (Mann Whitney test, both p < 0.01), and the 
possibility of a circulating anticoagulant, functioning in a similar way to heparin, 
remains an important consideration.
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4.3.3.2 Plasma heparan sulfate levels
1300-
E3 OFI (n = 21)
□  D engue infection (n = 165)120 0 -
1100  -
100 0 -
9 0 0 -
8 0 0 -
7 0 0 -
6 0 0 -
5 0 0 -
4 0 0 -
3 0 0 -
2 0 0 -
1 0 0 -
0-
2
(n = 2,2)
3
(n = 11,15)
4
(n = 4,28)
5
(n = 9,58)
6 7
(n = 9,64) (n = 11,84) (n = 6,66)
8 9 FU
(n = 2,27) (n = 12,102)
Days from onset of fever
The total number of patients included in each group each day is indicated on the X axis. 
Figure 4-2: Box and whisker plots showing daily heparan sulfate levels in adults
with dengue and OFI
We observed that plasma HS levels were markedly increased in the dengue patients 
with the same time profile as that of vascular leakage (i.e. peaking at day 6 o f illness 
and subsequently improving, Figure 4-2). The levels observed here were considerably 
higher than those measured with the same kits in patients with 
mucopolysaccharidoses, the disease in which there is deficiency or dysfunction of 
lysosomal enzymes needed to degrade GAGs [124].
Figure 4-3 shows that HS levels correlated strongly with both vascular leakage (Mann
Whitney test, both p < 0.001) and bleeding severity (Cuzick test for trend, both p <
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0.01) in the critical and convalescent periods in the dengue patients. Since HS levels 
may be artificially increased due to the effect of the haemoconcentration phenomenon 
seen in dengue patients with vascular leakage, we corrected the values using the 
following method. Firstly, percentage HCT change was calculated for the HCT value 
on the same day with reference to the baseline value. If the percentage HCT change 
on this day was > 10% (HCT changes of less than 10% from baseline are accepted as 
within normal daily variability), then the HS level was corrected as follows: corrected 
HS level = measured HS level/(l + percentage HCT change). After we corrected HS 
levels, the correlations with both vascular leakage and bleeding severity in the critical 
and convalescent periods still existed (Figure 4-4). As expected, we saw the extent of 
the correction in patients with shock was greater than in those without shock.
We looked for correlations between HS levels and the overall percentage 
haemoconcentration (as a marker of vascular leakage severity) and with the results of 
other laboratory markers measured concurrently during the critical period. HS levels 
demonstrated moderate to strong negative correlations with the platelet count 
(Spearman correlation of -0.69, p < 0.001, n = 149) and plasma fibrinogen levels 
(Spearman correlation of -0.36, p < 0.001, n = 129); and moderate positive 
correlations with APTT (Spearman correlation of 0.44, p < 0.001, n = 129) and 
percentage haemoconcentration (Spearman correlation of 0.36, p < 0.001, n = 142) 
(Figure 4-5). HS levels showed no correlation with PT (Spearman correlation of 0.09, 
p = 0.32, n = 129) or D-Dimers (Cuzick test for trend, p = 0.29).
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Chapter 4 - Exploring the mechanisms responsible for the increase in APTT
HS measurements in the non-dengue disease controls showed that although HS levels 
were increased in some severe malaria patients, the measured values were 
considerably lower than those seen in the dengue infected patients. In the other 
disease control groups HS levels were generally low and similar to the findings in the 
OFI group (Figure 4-6).
.»
D  Dengue without shock  (n = 111) D  Severe malaria (n = 25)
H D S S  (n = 29) □  Bacterial meningitis (n = 26)
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Figure 4-6: Box and whisker plots presenting HS levels for the dengue patients 
with and without shock (levels from the critical period, corrected for 
haemoconcentration), and for various non-dengue disease controls
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4.3.3.3 Heparinase experiments
Optimization of the conditions: Ca concentration and incubation time
To establish the optimal conditions for the subsequent experiments we used NPP from 
healthy volunteers. To do this we obtained 5 ml venous blood samples from 10 
healthy volunteers, taken into standard citrated collection tubes. After separation, we 
pooled the plasma from all 10 donations to produce a pool of normal plasma. The 
plasma was then stored at -80 °C in 1 ml aliquots. We used the following reagents and 
preparations for these experiments:
a) Heparinase I and III enzymes (both 10 IU/mL) obtained from Ibex in liquid form 
and stored at -80°C.
b) Purified Heparan Sulfate (extracted from porcine intestinal mucosa) obtained from 
Sigma (USA) in powder form. Following the manufacturer’s instructions lmg HS 
powder was dissolved in 100pL sterile water to give a final concentration of 10,000 
pg/mL. Then the HS solution was divided and stored in aliquots in the fridge at 2 - 
8°C for one week.
c) Standard Calcium Chloride 10% (0.68 mo PL) solution was obtained from the 
hospital pharmacy, and diluted either 1:2 or 1:4 with sterile water to give the 
following CaC12 solutions - solution A (0.34 moPL) and solution B (0.17 mo PL). 
Calcium solutions were made fresh for each experiment.
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Table 4-3: Optimizing the Ca2+ concentration -  baseline APTT of NPP for this 
experiment was 29.5 / 29.4 seconds
Test NPP
volume
Volume of 
0.9%saline
Volume of 
CaC12
APTT (seconds) 
-  15 min delay
APTT (seconds) 
-  30 min delay
1 260 pL 4 pL 29.1 /29.4 29.2/29.6
2 260 pL 4 pL solution A 
(5 mmol/L)
19.7/20.0 18.6/18.4
3 260 pL 4 pL solution B 
(2.5 mmol/L)
27.6/26.7 27.5/26.6
The final concentration of the CaC12 used is indicated in brackets.
94- •Ca is necessary as a co-factor for heparinase enzyme activity, with ideal 
concentrations said to be between 2.5 and 5mmol/L, but Ca2+ itself may shorten the 
APTT. Therefore as a first step we measured the APTT in NPP after incubation with 
different calcium concentrations and after time delays of 15 and 30 minutes. Since the 
final concentration of coagulation proteins could also influence the APTT we ensured 
that the final volume of all samples in each experiment was the same, using 0.9% 
saline to balance the volume of any other reagents added (Table 4-3). Baseline and 
test APTT measurements were always performed in duplicate if the volume of plasma 
available allowed.
As expected, the APTT results were shorter in the presence of CaC12; with the 
concentration of 2.5mmol/L and a time delay of 30 minutes the APTT values were 
only slightly shorter than the baseline values.
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Spiking NPP with HS and attempting to reverse the effect on APTT with enzyme 
cocktails - Experiment 1
As a first step we added purified HS into NPP intending to mimic the high HS levels 
previously demonstrated in plasma samples from the dengue patients. As before, we 
corrected the volume of each test sample to a standard so as to ensure similar 
coagulation protein concentrations in all test samples, and we measured the APTT 
after incubating all the samples (with and without HS) at RT for 30 minutes. The 
purified HS clearly prolonged the APTT (Table 4-4, step 1).
In the second step we added different combinations of the heparinase enzymes (final 
concentration 0.2 IU/mL) with and without CaC12 (final concentration 2.5 mmol/L) to 
the remaining mixture of NPP plus purified HS (Table 4-4, step 2). We incubated all 
the samples at RT for 60 minutes to allow sufficient time for the enzymes to be 
effective. We then measured a standard APTT twice on each test sample.
When compared to the corresponding APTT results in step 1, the APTT results in step 
2 of the test samples without HS or heparinase enzymes (test samples 1 and 2) were 
slightly longer with a time delay of 60 minutes and with minor dilution with 0.9% 
saline. In the two test samples that were spiked with HS in step 1 but were incubated 
without enzymes in step 2 (test samples 3, 4) the APTT results were appreciably 
prolonged. In test samples that were spiked with HS and treated with enzymes (test 
samples 5 -1 0 ) , the APTT results improved significantly with all 3 enzyme mixtures 
but the effects were of different magnitude: heparinase III and I in combination (tests
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7, 8) was more effective than heparinase I alone (tests 9, 10), which in turn was more 
effective than heparinase III alone (tests 5, 6). In all cases the difference in APTT 
results between corresponding test samples with and without Ca2+ was around 5 
seconds, suggesting that the differences were more likely due to the effect of Ca2+ on 
the intrinsic coagulation process rather than as a direct result of Ca2+ on enzyme 
efficiency.
Spiking NPP with HS and attempting to reverse the effect on APTT with enzyme 
cocktails - Experiment 2
We went on to perform a similar experiment with NPP spiked with purified HS but 
without including CaC12, as suggested by the results of Experiment 1, but tried to see 
if lower concentrations of the enzymes and a shorter time of action (30 minutes vs 60 
minutes) would influence the results (Table 4-5). As before the results showed that the 
APTT results improved significantly with all 3 enzyme mixtures, again with effects of 
different magnitude: heparinase III and I (tests 5, 6) > heparinase I alone (test 7) > 
heparinase III alone (tests 3, 4). In addition, enzyme concentrations of 0.1 IU/mL had 
similar effects as enzyme concentrations of 0.2 IU/mL.
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Heparinase experiments with dengue patient samples
We had very limited supplies of the enzymes and the purified HS so were only able to 
perform a small number of experiments. A citrated plasma sample collected during 
the critical period from a patient with DSS was selected for this work. Although 
Experiment 2 above indicated that enzyme concentrations of 0.1 IU/mL for both 
heparinase III and I were likely to be as effective as concentrations of 0.2 IU/mL we 
decided to carry out the first experiment at 0.2 IU/mL in order not to miss any 
potential effects. The mixture of plasma and enzymes shown in Table 4-6 was 
incubated at RT for 30 minutes and then the APTT was measured twice.
Table 4-6: Heparinase effects on plasma from a dengue patient (DSS) -  
Experiment 1
Note the baseline APTT before enzyme treatment was 59.3/59.2 seconds
Test Volume of
citrated
sample
Volume 
of 0.9% 
saline
Volume of 
Heparinase III
Volume of 
Heparinase I
APTT (seconds) 
30 minutes 
delay
1 120 pL 6 pL 61.2/61.3
2 120 pL 3 pL 3pL (0.2 IU/mL) 61.5/60.8
3 120 pL 3pL (0.2 IU/mL) 3 pL (0.2 IU/mL) 61.6/63.3
4 120 pL 3 pL 3 pL (0.2 IU/mL) 61.7/61.4
The results showed that APTT results in the test samples treated with enzymes (tests 2 
-  4) were similar to the result of the test sample without enzymes (test 1). Thus we 
saw no reversal of the APTT for any combination of enzymes used, different to the 
responses we had seen in the experiments on NPP spiked with purified HS. One 
possible explanation could be that reversal of the APTT when HS is degraded by
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heparinases may not be apparent if there is also significant deficiency of coagulation 
factors as might occur in dengue patient samples. Therefore we carried out a further 
experiment (Table 4-7) in which we added the cocktail of heparinase I and III 
enzymes and CaC12 into a citrated plasma sample obtained during the critical period 
from a confirmed DSS patient, incubated the mixture at RT for 60 minutes, and then 
went on to perform immediate 50/50 and 80/20 APTT mixing studies on plasma 
samples with and without enzyme treatment. The results showed that the APTT of the 
test samples (i.e. with enzymes) were similar to the results of the corresponding 
samples without enzyme treatment. Finally we repeated a similar experiment 
(Experiment 3, Table 4-8) with a citrated sample from another dengue patient during 
the critical period, this time using very high concentrations of the enzyme mixture 
(0.4 and 0.6 IU/mL). Again, we saw no additional effect of enzyme treatment, over 
and above the effects of adding NPP in either 50/50 or 80/20 ratios.
Although we had planned to measure plasma HS levels in the dengue samples before 
and after the various experiments described above we were unable to do so, as 
Seikagaku, the Japanese manufacturer of the HS ELISA kits, had had to discontinue 
the research arm of their business after the Japanese tsunami. We were able to 
perform one small experiment with two plasma samples from DSS patients; we 
measured HS at very high levels (439 and 572 pg/mL) in these samples. Then we 
treated the samples with heparinase I and III at concentrations of 0.2 IU/mL and under 
standard conditions (RT, time incubation of 30 minutes and without CaC12) and 
repeating the HS ELISAs. In both cases plasma HS was undetectable after the enzyme 
treatment indicating that this mixture of enzymes does fully degrade the endogenous 
HS found in dengue patients’ plasma.
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4.4 Discussion and conclusion
The work presented here supports previous work from Vietnam indicating that the 
pattern of coagulopathy seen in dengue patients is not typical for DIC. Similar to the 
paediatric studies this adult study indicates that the main coagulation abnormalities 
present are an increase in the APTT and a reduction in fibrinogen levels, with little 
evidence of pro-coagulant activation. Although HS levels were markedly increased in 
the dengue patients, the APTT mixing studies indicate that the primary mechanism 
responsible for the prolonged APTT is likely to be coagulation factor deficiency.
We know that many coagulation factors carry negative charge on their surface and are 
also small in size, with molecular weights typically similar to or less than that of 
albumin (Table 1-1); in normal conditions these characteristics help to protect the 
proteins from leakage. However, this protection seems to be impaired in dengue 
infection, as shown in the previous study from the OUCRU group that demonstrated 
increased clearances of both negatively charged albumin and neutral transferrin, as 
well as leakage of the similarly sized, negatively charged coagulation protein, 
antithrombin [57]. Thus leakage of essential coagulation factors is a plausible 
mechanism for the coagulation factor deficiency seen in dengue.
Another question raised by these results relates to why, if the APTT is prolonged due 
to leakage of essential coagulation proteins, a similar effect is not apparent for the 
PT? Coagulation factor VII, one of the proteins crucial for initiating the PT response 
is also a small molecule (molecular weight 48,000 Daltons) (Table 1-1) and would be
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expected to leak alongside other relatively small coagulation proteins. The APTT is 
dependent on a greater number of coagulation factors (factor XII, XI, IX, VIII, X, V, 
II and I) than the PT (factor VII, X, V, II and I) [63,121], and thus it is possible that it 
is more affected by global deficiency of coagulation factors due to leakage. In 
addition, it is known that the activated form of factor VII (FVIIa) normally circulates 
in very tiny amounts in plasma (accounting for only approximately 1% of the total 
factor VII mass), and that the Tissue Factor - Factor Vila complex that is the starting 
point for the procoagulant response rapidly triggers an exponentially increasing 
coagulation cascade. A negative effect on clotting may only become apparent when 
there is substantial deficiency of total factor VII mass [125]. It seems very likely that 
Factor VII deficiency does occur in dengue patients with vascular leakage but that in 
the majority of cases this deficiency is not sufficient to alter the PT.
Further studies could be considered to investigate whether leakage of essential 
coagulation factors is the main mechanism underlying the prolonged APTT with a 
normal PT that is the characteristic finding in dengue patients. Since systemic and 
renal ultrafiltration processes are similar, urine is sometimes used as a surrogate for 
interstitial fluid when assessing protein leakage [57,126]. The ratio of the 
concentration of a particular protein to the creatinine concentration in a random urine 
sample is a simple method that is accepted to assess urinary protein excretion - there 
is a good correlation between that ratio and the amount of protein excreted in a 24- 
hour urine collection, provided renal function is stable [127]. Thus one possibility
120
Chapter 4 - Exploring the mechanisms responsible for the increase in APTT 
would be to measure serial plasma concentrations of specific coagulation factors, 
together with urinary concentrations of these factors, to understand the leakage pattern 
throughout the course of illness. Secondly, haemostatic balance (and therefore the 
results of coagulation screening tests such as the PT and APTT) is dependent on the 
activities of the different coagulation proteins rather than concentrations of these 
factors per se - although clearly activity and concentration of an individual factor are 
closely linked. So, serial measurements of coagulation factor activities together with 
simultaneous plasma concentrations could also be informative. However, given the 
large number of different coagulation factors involved in normal haemostasis, and the 
fact that specific investigations are very expensive, the question of which particular 
factors should be included in a detailed study of this nature becomes important. The 
APTT is dependent on factors of both the “intrinsic” and common pathways. If  there 
is significant deficiency of coagulation factors of the common pathway alone, both PT 
and APTT would be expected to be prolonged [63]. Thus the isolated increase in 
APTT in dengue suggests deficiency of coagulation factors of the “intrinsic” pathway 
and all factors (XII, XI, IX and VIII) in this pathway should be included. 
Comparisons of the patterns seen for Factors VIII and XI (large molecules) with those 
of Factors IX and XII (small molecules) would be interesting. Factor VII, representing 
the “extrinsic” pathway would also be interesting to measure, as this may suggest why 
the PT is not prolonged. However a significant drawback to this kind of study relates 
to the complex nature of the coagulation cascade with multiple interactions and
feedback loops, and the wide range of normal values for individual parameters.
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Interpretation of results for individual factors is difficult, and statistical analysis is 
complex given the large number of tests performed and the possible interactions. 
Samples from very large numbers of patients, carefully collected to minimize 
activation of coagulation during venesection, would be needed to give reliable results.
The experiments with heparinase enzymes suggest that, although present at very high 
concentrations, the HS molecules do not have significant anticoagulant properties. 
However since we were unable to complete the detailed studies that were initially 
planned due to discontinuation of the ELISA kits, further work is needed before this 
question can be answered definitively. Although we could not measure HS levels in 
the patient samples used for the APTT reversal experiments, two of the samples used 
were obtained from DSS patients in the critical period and in our previous experience 
samples from these patients at this time generally show marked elevation of HS levels 
(Figure 4-3). If these samples did indeed have high HS levels, there are several 
possible explanations for the failure of an additional effect on the APTT following 
treatment with the heparinase enzymes. One possibility is that the HS molecules 
present in the dengue patient plasma are structurally different to the purified HS 
preparation used for the spiking experiments; HS exists in many forms and it is 
generally thought that a particular antithrombin binding motif must be present for HS 
to exert an anticoagulant effect. Alternatively, HS molecules carry a strong negative 
charge and likely interact with many other plasma constituents; in particular HS is 
known to interact with dengue NS1, a protein often present in large amounts during
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the critical phase of dengue infections. If this interaction, or any other interactions 
with inflammatory or other molecules that may be present in acute dengue plasma, 
prevent the binding of the heparinase enzymes to the HS molecules, then it is possible 
that the enzymes might be ineffective.
We are currently engaged in additional studies to investigate these possibilities 
further. Working in collaboration with specialist biochemists at Harvard MIT we are 
attempting to extract and characterize the HS molecules from dengue plasma, aiming 
to see whether the molecules carry binding sites for antithrombin, as well as to 
identify the likely site of origin of the molecules. HS molecules derived from different 
sites carry different signatures and we will look particularly to see if the HS molecules 
carry the signature of endothelial HS, suggesting release from the endothelial surface 
glycocalyx layer. We are also hoping to develop a new HS ELISA to replace the 
Seikagaku system, using the same monoclonal antibodies. If this is successful we will 
then be in a position to look again at whether HS present in dengue patients’ plasma is 
degraded by heparinase enzymes.
Understanding the mechanisms responsible for the typical dengue related 
coagulopathy is important as there may be clinical implications. Thus dengue-infected 
patients with severe bleeding should receive fresh frozen plasma promptly to replace 
the coagulation proteins lost through plasma leakage, and consideration should be 
given to treatment with cryoprecipitate. Although this study did not focus on leakage 
of fibrinogen there is evidence from other work that fibrinogen leaks at a similar rate
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to much smaller proteins [128], possibly related to its elongated shape, and since 
severe patients invariably have very low plasma fibrinogen levels replacement therapy 
may be necessary for patients who bleed. Finally if true anticoagulant properties were 
to be demonstrated for the HS present in plasma, then consideration might be given to 
use of agents such as protamine sulfate for dengue patients with severe bleeding; 
protamine sulfate is a cationic drug that binds negatively charged heparin molecules 
and is sometimes used to reverse unwanted effects of excessive anticoagulation.
124
Chapter 5
Circulating endothelial cells in dengue infection
125
Chapter 5 - Circulating endothelial cells in dengue infection
5.1 Introduction
CECs are thought to originate when endothelial cells detach from blood vessel walls 
following some form of pathological insult. Enumeration of CECs has been developed 
as a non-invasive technique to explore vascular endothelial dysfunction in various 
disease states -  systemic lupus erythematosus and other inflammatory vasculitides, 
chronic kidney diseases, thalassaemia, sickle-cell anaemia, rickettsial infections, 
cancer etc. There is also growing evidence that CECs can be used as biomarkers of 
vascular disease [66,92,129]. Finally, as well as reflecting vascular damage it appears 
that CECs may themselves participate in the pathogenesis of some disorders, possibly 
by the expression of active molecules such as thrombomodulin or tissue factor on the 
surface of the cells [66].
Different techniques including in vitro culture, magnetic bead isolation and 
fluorescence-activated cell sorting (FACS) have been used to detect these cells, but 
increasingly FACS analysis has emerged as the preferred option [130,131]. To date 
there have been only two studies that measured CEC numbers in dengue infection but 
the results were limited. One small study in Venezuela found that numbers of CECs 
measured by FACS analysis were increased in four dengue patients compared to 
healthy subjects [132]. In the other study a group in Thailand measured serial CEC 
numbers, using the buffy coat smear technique, in 103 children with dengue infection 
and 8 children with OFI. They found that CEC numbers appeared to correlate with 
clinical disease severity at the time of defervescence and a few days after that [133].
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In this chapter I will describe a more detailed study performed to characterize the 
CEC profile as it evolves in dengue patients from the early febrile phase, and to 
examine whether there is an association between percentage of CECs detected and 
disease severity described independently in terms of vascular leakage and bleeding 
severity. In addition, I will describe the relationship between CEC percentages and 
concurrent plasma HS levels, used here as an alternative marker of endothelial 
dysfunction.
5.2 Methods
We chose to focus recruitment for this study on adolescents and young adults, aiming 
to capture patients within the age range most likely to experience severe 
vasculopathy/shock during dengue infections. We did not recruit children below 12 
years of age as the study protocol required larger blood volumes than is usually 
considered acceptable for sick children in Vietnam. General clinical, laboratory and 
statistical methods are presented in Chapter 2. Additional specific methods are 
presented below.
CEC Enumeration: This was carried out according to the Standard Operating 
Procedure (SOP) kindly provided by Dr. Andrew Blann from the University 
Department of Medicine, City Hospital, Birmingham (UK). The technician who 
performed CEC enumeration for the samples in this study was blind to all clinical 
information.
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We used a BD FACSCanto II flow cytometer and the following reagents from BD 
Biosciences (USA): FITC Mouse Anti-Human CD45 (555482); PE Mouse Anti- 
Human CD146 (550315); and 7AAD (559925). Briefly, two aliquots (0.4 ml venous 
blood per aliquot) were used as the test sample and an isotype control. The test 
samples were incubated with a mixture of the two fluorochrome-labeled monoclonal 
anti-human mouse antibodies and 7AAD, a chemical marker that differentiates 
between dead and live cells, for 30 minutes on ice in the dark. For the isotype 
controls, PE Mouse IgGi k  Isotype Control (555749) was used to replace PE-CD146. 
Isotype controls are a type of negative control designed to measure the level of non­
specific background signal caused by the primary antibodies -  the antibody is chosen 
to be similar to the test antibody but without the specific binding site of interest. After 
this staining step, test samples and isotype controls were treated similarly. Firstly, red 
blood cells in the sample were lysed twice using 3ml of pre-diluted BD lysing buffer 
(349202) for 10 minutes, and then the sample was centrifuged at 2000 rpm for 5 
minutes to collect the white blood cells (WBC). The cells were washed with 3ml of 
phosphate buffered saline (PBS) solution and centrifuged to re-pellet the cells. Then 
0.4ml of 2% paraformaldehyde was added to fix the cells before analysis by flow 
cytometry. Viable CECs were defined as CD457CD146+/7AAD' and dead CECs were 
defined as CD457CD146+/7AAD+. Full strategy and representative flow cytometer 
plots are shown in Figure 5-1.
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The figure shows the results of the test sample and isotype control from one sample to 
illustrate the typical findings.
Sequential gating strategy for CECs: (A) Forward (FSC) and side scatter (SSC) plot of 
all cell events and gating region PI to include all mononuclear and polymorphonuclear 
cell events while excluding platelets, dead cells, and microparticles. (B) Dump channel 
to exclude CD45+ cells and high side scatter events (region P2). (C) Cellular events from 
gated region P2, with viable CECs as CD146+/7AAD' population and dead CECs as 
CD146+/7AAD+ population.
Figure 5-1: CEC enumeration by flow cytometry
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As CECs are rare events, we followed the recommendations for enumerating rare 
events by flow cytometry, including thoroughly cleaning the cytometer before data 
acquisition and also collecting the largest numbers of all events possible (the 
maximum number was set up at 1.5 million cell events) [130]. In addition, using 
FlowJo software version 7.6.5 (Oregon, USA), we calculated the minimum number of 
total events in the blood mononuclear and polymorphonuclear cell population (PI) 
that should be acquired to ensure adequate reproducibility (aiming for a coefficient of 
variation (CV) less than 10%) of the results, based on the method described by 
Donnenberg at al [134]. Based on this initial assessment all samples with total cell 
events < 450,000 in PI were excluded from the analysis (see section 5.3.2). CEC 
results can either be reported as a percentage of CEC events in the PI population from 
the FACS analysis, or as an absolute count of CECs/mL. Although absolute counts of 
CECs relative to a total WBC measurement obtained from a simultaneous full blood 
count are commonly quoted, there are several reasons why this may not be optimal. 
Firstly these are rare events and therefore calculation of absolute numbers relative to a 
measurement obtained on a different blood sample is not ideal; comparison to a 
marker assessed in the same sample is preferable. Secondly the method assumes that 
the total WBC is equivalent to the WBC plus CECs which is not strictly speaking 
correct. As well as taking the two measurements on exactly the same aliquot of blood, 
since the PI population represents all nucleated cellular elements of blood, including 
CECs, white blood cells and fibroblasts, assessing CECs as a percentage of PI is 
considered more accurate. Therefore, in developing the analysis plan for this study we 
chose the percentage of total CECs (viable and dead cells) in PI in the test samples
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examined at intervals during the evolution of the illness as the primary outcome of 
interest, and the absolute count of total CECs as a secondary outcome.
Heparan Sulfate ELIS As: HS levels were subsequently measured in batches using 
residual EDTA plasma that was frozen and stored at -80°C after the CEC 
enumeration. The levels were measured using commercial HS ELISA kits (Seikagaku, 
Japan) following the manufacturer’s instructions. All other laboratory assays were as 
described in Chapter 2.
5.3 Results
5.3.1 General clinical and laboratory information of the cohort
Between December 2010 and June 2011, 95 patients with suspected dengue were 
recruited into the study, including 59 patients in the infection wards plus 36 patients 
in the ICUs. Dengue was confirmed in 73/95 (77%) patients while 15 (16%) patients 
were classified as OFI. In the remaining 7 patients (7%) the results of serological and 
virological diagnostics were inconclusive. A single infecting serotype was identified 
in 52/73 (71%) of the dengue patients -  DENV 1 in 21/52 (40%), DENV 2 in 23 
(44%), DENV 3 in 4 (8%) and DENV 4 in 4 patients (8%). Four patients had mixed 
infections. Among the 73 patients with confirmed dengue, only one patient was 
initially recruited on one of the infection wards and then transferred to the AICU - a 
19 year old female with severe bleeding related to a ruptured ectopic pregnancy. All 
suspected dengue patients enrolled in the study recovered fully and 49 patients (52%) 
attended the follow-up visit.
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We enrolled 13 patients with confirmed malaria, including 10 patients with non- 
severe malaria (6 plasmodium vivax, 3 plasmodium falciparum and 1 mixed 
vivax/falciparum infection) and 3 patients with severe malaria, all due to plasmodium 
falciparum. All malaria patients enrolled in the study recovered fully and 4/13 patients 
(31%) attended for follow-up visits. Twenty healthy young adults were also recruited, 
including 10 female and 10 male volunteers with a median (90% range) age of 23 (23 
-  25) years.
Table 5-1 presents summary demographic, clinical and laboratory information for the 
patients with confirmed dengue, OFI and malaria. In this study, more female patients 
were enrolled than male patients in both dengue infection groups. However, malaria 
mainly affected male patients, probably as a result of occupational exposure. As 
expected, dengue patients had more skin and mucosal bleeding while the majority of 
patients with OFI and malaria had no bleeding. Other than shock, 4 of the dengue 
patients experienced severe complications (2 with severe bleeding, one with 
encephalopathy and one with haemophagocytosis). In the malaria group, 3 patients 
developed jaundice, 2 were encephalopathic and one had renal failure. No 
complications were seen in the OFI group.
Percentage haemoconcentration was significantly greater in dengue patients with 
shock than those without shock (Mann Whitney test, p < 0.001). In many malaria 
patients the percentage HOT change was negative, likely reflecting the effects of 
major haemolysis during the acute illness. We also found typical coagulation 
abnormalities among the dengue patients including thrombocytopenia, increased 
APTT and reduced plasma fibrinogen levels, with more severe derangements seen in
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the patients with shock. In both dengue severity groups the PT was similar to the 
results for the OFI patients and the D-Dimer test was clearly positive in less than one 
third of the patients. Malaria patients also had quite marked thrombocytopenia, but 
there was no increase in APTT and the fibrinogen levels were increased rather than 
decreased, consistent with an acute phase response. Similar to Chapter 4, we found 
HS levels was markedly increased in the dengue patients compared to OFI and 
malaria patients, with significantly higher levels seen in dengue patients with shock 
compared to those without shock (Mann Whitney test, p < 0.001).
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Chapter 5 - Circulating endothelial cells in dengue infection
5.3.2 Optimization of the CEC analysis
We performed CEC enumeration for 283 samples in total. To determine the minimum 
number for total cell events in PI, we randomly chose three samples with a large 
number of total cell events (at least 1,300,000 events). Then we analyzed the variation 
in the percentages of CECs (CD45'/CD146+ population) identified in 9 different 
gating plots with increasing numbers of total cell events in PI (7,000 increasing to 
640,000 events). Each gate was repeated three times and the CV calculated; a CV of < 
10% was achieved when approximately 450,000 cells per replicate were analyzed, a 
cut-off that is quite similar to the suggested number of total cell events indicated in a 
review article about CEC enumeration by flow cytometry [130]. We therefore 
included only the 259 samples (92%) which had a total event number in PI > 450,000 
for the analysis. In addition one dengue patient on the AICU also had thalassemia, a 
condition known to be associated with very high CEC numbers [135], so we also 
excluded this patient from the analysis.
5.3.2.1 Comparison of CEC results in the test samples and isotype controls
For all samples eventually included in the analysis, serial results for the total CEC 
percentage (of both viable and dead cells) in the PI population in the test samples and 
the isotype controls are shown in Figure 5-2. Serial results for the total CEC absolute 
counts are shown in Figure 5-3. As the pattern and evolution of changes was very 
similar to the percentage CEC results we present statistical comparisons for the 
percentage CEC data only.
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The findings confirm that CECs are very rare events. Despite this we were able to 
detect significant changes in the CEC results over time and in comparison with the 
different control groups. In the healthy volunteer group the median (90% range) for 
the total CEC percentage in PI in the test samples was 0.0001 (0 -  0.0005)%, 
equivalent to a median (90% range) for the absolute CEC count of 8 (0 -  40) 
cells/mL. In the isotype control samples, CECs were undetectable in almost all the 
healthy volunteers although small numbers were found in the patient groups with 
dengue, OFI and malaria. This suggests that some non-specific cellular binding of the 
markers occurs during acute infections, when many inflammatory pathways are 
upregulated. In the OFI and malaria groups, the results for CECs detected in the test 
samples were similar to the results seen in the corresponding isotype control samples. 
By contrast the CEC results in both dengue patient groups were substantially higher in 
the test samples than the isotype controls.
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Chapter 5 - Circulating endothelial cells in dengue infection
5.3.2.2 Evolving changes in CEC percentages in the dengue patients and the 
disease controls.
As shown in the left panel of Figure 5-2, there was no apparent change over time in 
the total CEC percentages in the test samples from the OFI and malaria patients. In 
the group of dengue patients without shock, the total CEC percentages in the early 
febrile period were similar to the values at follow-up (median (90% range) of 0.0002 
(0 -  0.0015)% compared to 0.0003 (0 -  0.0014)%, p = 0.16), but increased 
significantly in the critical period (median (90% range) of 0.0007 (0.0001 -  
0.0055)%, p = 0.02), and remained elevated during the convalescent period (median 
(90% range) of 0.0009 (0 -  0.004)%, p = 0.01), all comparisons being with the 
follow-up values in the same patient using the Wilcoxon signed-rank test. Only one 
patient with DSS was captured in the early febrile period (CECs = 0.014% of PI); 
otherwise this group showed a similar evolution in CEC percentages during the course 
of the illness to the dengue patients without shock, although with a more marked 
increase during the critical period. Thus the median (90% range) during the critical 
period was 0.001 (0.0002 -  0.0046)% and during the convalescent period was 0.0006 
(0.0001 -  0.003)% compared to 0.0001 (0 -  0.0017)% at follow-up (both p < 0.01 for 
comparisons of critical and convalescent values with follow-up values, Wilcoxon 
signed-rank test).
In addition, during both the critical and convalescent periods the total CEC 
percentages detected in the dengue patients without shock were significantly higher
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than those seen in the OFI or malaria patients (p < 0.01 for all comparisons, Mann 
Whitney test).
5.3.2.3 Correlations between CEC percentages with clinical and laboratory 
markers of disease severity in the dengue patients
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Figure 5-4: Box and whisker plots showing changes in total CEC percentage (left 
panel) and in viable CEC percentage (right panel) in the test samples during the 
course of illness and at follow-up, in confirmed dengue patients with and without 
shock.
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Figure 5-4 shows results for total CEC percentages (viable and dead cells) and for 
viable CEC percentages alone, in the test samples of the dengue patients, presented 
according to vascular leakage severity. The figure shows that viable CECs accounted 
for the majority of total CECs at all time-periods. Although apparently more elevated 
in the DSS cases during the critical period, neither total CEC percentages nor viable 
CEC percentages were statistically significantly different between the dengue patients 
with and without shock (all p > 0.1 in both the critical and convalescent periods, 
Mann Whitney test). In the four dengue patients with severe complications other than 
shock total CEC percentages were also markedly elevated, ranging from 0.001 - 
0.0034% in the critical period.
In addition, both total CEC and viable CEC percentages were significantly correlated 
with bleeding severity in the critical period (Cuzick test for trend, both p < 0.05) but 
not in the convalescent period (data not shown). In terms of correlations between CEC 
percentages and other key laboratory results, during the critical period total CEC 
percentages demonstrated mild or moderate negative correlations with concurrent 
platelet counts and plasma fibrinogen levels (Spearman correlations of -  0.29 and -  
0.39, both p < 0.05, n = 52 and 51, respectively) and moderate positive correlations 
with concurrent PT, APTT and HS levels (Spearman correlations of 0.34 to 0.45, all p 
< 0.05, n = 51, 51 and 49, respectively) but no correlation with overall percentage 
haemoconcentration (Spearman correlation of 0.02, p = 0.88, n = 46). However, HS 
levels demonstrated a strong positive correlation with overall percentage
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haemoconcentration (Spearman correlation of 0.63, p < 0.001, n = 54) and stronger 
correlations with the other key laboratory values measure during the critical period. 
Thus HS levels demonstrated strong negative correlations with concurrent platelet 
counts and plasma fibrinogen levels (Spearman correlations o f -  0.71 and -  0.55, both 
p < 0.001, n = 63 and 62, respectively), a moderate positive correlation with the 
concurrent PT (Spearman correlation of 0.42, p = 0.001, n = 62), and a strong positive 
correlation with concurrent APTT values (Spearman correlation of 0.60, p < 0.001, n 
= 62). Figure 5-5 shows the correlations between the total CEC percentage with 
percentage haemoconcentration, concurrent platelet count and APTT (as one example 
of the different coagulation tests performed) and indicates that for each parameter the 
correlations were stronger with plasma HS levels than with CEC percentages.
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5.4 Discussion
This study has shown that CEC percentages clearly increase during the critical and 
convalescent periods of dengue infection and then return to the normal range within 
one month after the illness. Very similar patterns were observed using the absolute 
CEC count/mL as the outcome of interest. The pattern of a transient increase that 
follows the expected clinical evolution of the disease was not seen in the non-dengue 
disease controls, either in the OFI or the malaria groups. CEC percentages correlated 
significantly with the majority of clinical and laboratory markers of dengue disease 
severity, although no clear relationship was demonstrated with respect to vascular 
leakage severity assessed in terms of development of DSS and overall percentage 
haemoconcentration. We were unable to investigate whether increases in CECs during 
the early febrile period might be a useful predictor for the subsequent development of 
shock, because only one patient recruited during this time went onto develop DSS.
CECs are rare events in blood and enumeration is challenging. Debate continues as to 
the best method for measurement of these cells and a standard protocol using flow 
cytometry remains to be agreed upon [130,131]. Problems include concerns that 
CECs detected in this way might in fact be large platelets, activated lymphocytes or 
circulating progenitor cells (CPCs). CPCs are rare cells, derived from bone marrow, 
that circulate in the blood and can differentiate into endothelial cells, thus playing an 
important role in vascular repair. For this study we used the protocol from a research 
institution in Birmingham (UK) that has established a reputation in the field and
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published several studies about CECs in cancer, vascular diseases etc. The 
Birmingham protocol uses CD 146 and CD45, by which we can exclude platelets, 
which do not express CD 146, and activated lymphocytes, which do express CD45. 
However, CEC events detected by this method could include some CPCs because 
they have the same CD45-/CD146+ profile as CECs and the protocol does not include 
specific markers for progenitor cells, such as CD 133 or CD34. Some authors do 
suggest, however, that CD 146 positive cells are all CD 133 negative [129], but even so 
it is possible that the population of CECs we identified did include some CPCs. We 
were also careful to follow general guidelines for enumeration of rare events by 
FACS, thereby minimizing contamination and ensuring an adequate population of 
cells in PI. Finally in support of the technique we used, the results for CEC absolute 
counts in healthy volunteers in this study were low (median (90% range) of 8 (0 -  40) 
cells/mL), and in keeping with the ranges previously published for healthy persons by 
the Birmingham group using similar techniques [92,136]. Compared to results from 
other studies investigating endothelial involvement in conditions such as 
cardiovascular disease, cancer, vasculitis and septic shock, the magnitude of the 
increase in CECs in the dengue patients was similar or slightly higher than the 
findings in these diseases [66,129]. We believe that these results do reflect relative 
changes in the CEC population in these patients, but it should be emphasized that 
such rare event analysis is difficult and it is the evolution over time that is most 
convincing rather than changes in the CEC percentages measured. By contrast HS 
plasma levels are much more easily measured, requiring only standard ELISA
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methodology, and varied between <10pg/mL to >lmg/mL in the dengue patients in 
this study. Thus clear differences between patient groups and over time are 
considerably easier to identify.
Previous studies showing increases in plasma levels of soluble cell adhesion 
molecules, and several endothelial related coagulation factors such as tissue 
plasminogen activator, thrombomodulin and von Willebrand factor [86,89,132,133], 
have confirmed that the vascular endothelium is affected during dengue infections, 
but our results provide direct evidence of damage sufficient to cause shedding of 
endothelial cells, albeit in small numbers. The majority of the CECs identified were 
viable cells and this suggests that the endothelial cells were recently shed during the 
course of illness.
The parallel increases in both CECs and HS levels support the theory that disruption 
of the endothelial cell/glycocalyx complex occurs during dengue infections - i.e. 
CECs appear to be shed from the endothelial layer while HS may be shed from the 
surface glycocalyx. These disruptions likely affect the function of the complex and 
could contribute to the pathogenesis of systemic vascular leak syndrome and 
haemostatic derangement. Although clearly elevated, we did not show strong 
correlations between CEC percentages and severity of vascular leakage assessed in 
terms of development of DSS or overall percentage haemoconcentration -  however, 
HS levels correlated strongly with both these parameters. Accepting the caveat that 
CEC changes are more difficult to measure, these results could indicate that
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disruption of the surface glycocalyx layer during dengue infections is more 
pronounced than the effects on the underlying endothelial layer.
CEC percentages correlated significantly with bleeding severity and laboratory 
markers of coagulation derangement, such as the platelet count, PT, APTT and 
plasma fibrinogen levels, and it may be that CECs themselves participate in the 
coagulopathy through expression of molecules such as tissue factor or 
thrombomodulin that are active in the procoagulant or anticoagulant pathways. In 
order to characterize whether the CECs express these active molecules further studies 
would be needed. For example CD 142 is an established marker for tissue factor 
expressions and it should be possible to design a protocol using this marker together 
with the markers used for CEC enumeration to identify whether the CECs express 
tissue factor.
In summary, serial enumeration of CECs among 73 patients with dengue, 15 with OFI 
and 13 with malaria showed that CECs were significantly increased in the dengue 
patients but not in the patients with OFI or malaria. CEC percentages correlated with 
several markers of disease severity, following a similar pattern during the course of 
the illness, but we did not demonstrate a clear association with development of shock. 
Other studies enrolling a larger number of patients early in the illness course, and 
including additional characterization of the CECs identified, could help to give more 
information on the role of CECs in dengue pathogenesis and also to answer the 
question whether early increases in CECs can be used as a prognostic factor for 
subsequent disease outcome.
147
Chapter 6 
Conclusion
148
Chapter 6 - Conclusion
6.1 Contributions of the thesis
The work described in this thesis provides several important contributions to our 
knowledge about clinical dengue disease, as well as filling significant gaps in our 
understanding about the pathogenesis of haemorrhage associated with dengue. 
Firstly, the comprehensive clinical studies performed as part of this work have 
confirmed the empirical view that vascular leakage is more severe in children than 
adults and that DSS occurs more frequently in this age group, while haemorrhagic 
manifestations and organ impairment are more commonly seen in adults. Previous 
reports describing the complications seen have generally focused on either paediatric 
or adult populations, depending on the local epidemiological pattern of disease, but 
have rarely looked across the age spectrum in a particular geographical location. In 
this study we assessed the rate and severity of complications among direct admissions 
of all ages to a single hospital in a hyper-endemic region. Although broad-based 
recruitment at a community level would likely have provided a clearer picture of the 
patterns of disease by age, such a study would not be feasible in our setting and we 
are confident that the pattern of complications documented here is representative of 
true differences in response to dengue infection by age. Secondary infections clearly 
play a role in determining disease phenotype, but age-related intrinsic physiological 
responses are also important. Thus children, who have intrinsically higher 
microvascular permeability tend to develop vascular leakage and DSS, while adults, 
with intrinsically lower platelet numbers [107], and a greater likelihood of having
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concomitant disorders that compromise mucosal integrity such as peptic ulcers [108], 
tend to experience bleeding complications.
The clinical studies also revealed that liver involvement, demonstrated by increased 
transaminase levels, occurs in almost all adults with dengue but is rarely associated 
with severe complications. PT values were normal in the majority of patients (except 
for the rare cases with acute liver failure) suggesting that generally the liver 
involvement does not contribute to the haemostatic derangements that are a frequent 
feature of infection.
The finding that thrombocytopenia was not only more severe in adults during the 
evolution of dengue disease, but that platelet counts were also significantly lower in 
adults than children after recovery, is novel. Only one published study has examined 
platelet counts by age in a healthy population [107], with similar results to our 
findings. Our results indicate that the more pronounced thrombocytopenia seen in 
adults with dengue likely reflects similar disease-associated effects superimposed on 
intrinsically lower normal platelet values in adults compared to children. Work by 
other authors has shown that in patients with dengue the residual platelets are also 
dysfunctional [74], and there has been some recent evidence that the dengue virus 
may actually replicate within platelets [83].
The pattern of coagulopathy seen in adults included mild to moderate prolongation of 
the APTT with reduction of plasma fibrinogen levels but only marginal prolongation 
of the PT and generally negative D-Dimers, very similar to the findings previously
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published on paediatric dengue [86,90]. This pattern would be unusual for DIC and 
the various experiments described here suggest that the increase in APTT is likely to 
be due in large part to deficiency of coagulation factors, most likely due to leakage. 
Antithrombin, a coagulation factor with a molecular weight of 58,000 Daltons 
(similar to that of albumin) and carrying a negative charge was shown to be markedly 
increased in urine from children with DSS [57], and it is likely that many other 
coagulation proteins with similar size and charge characteristics also leak. Although 
HS levels were markedly increased in the dengue patients, and the molecule is closely 
related to the synthetic anticoagulant heparin, we were unable to demonstrate 
anticoagulant activity in the dengue plasma; however work is ongoing to try to 
identify whether the HS carries the specific antithrombin binding sites thought to be 
necessary for anticoagulant function. Lastly, we examined changes in the percentage 
of CECs present in plasma at different stages during the evolution of dengue 
infection. CEC percentages were clearly increased in the dengue patients but not in 
those with OFI or malaria, and the CEC percentages correlated significantly with 
bleeding severity and the majority of the screening coagulation tests.
In summary, the pathogenesis of the haemostatic derangement associated with dengue
infections likely reflects a combination of several mechanisms including a) leakage of
essential coagulation proteins as part of the general systemic vascular leakage process
resulting in an imbalance of the coagulation system tipped towards anticoagulation
and b) thrombocytopenia with dysfunction of the remaining platelets. These factors
are together potentially exacerbated by high plasma levels of HS (that may exert
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intrinsic anticoagulant activity), and/or the presence of CECs (that may carry 
molecules that are important for regulation of the different coagulation pathways). In 
rare cases with acute liver failure, the haemostatic problems may be compounded by 
impaired coagulation factor synthesis in the liver. However, in the majority of dengue 
infections bleeding is very mild (skin petechiaie or bruising only) and 
thrombocytopenia is likely to be the dominant factor responsible. With increasing 
severity of disease the coagulopathy worsens and if tissue integrity is breached for 
any reason significant bleeding may result. Adults are much more likely to have 
underlying peptic ulcer disease or to experience gastritis with their dengue infection 
and this probably contributes to the greater risk for gastrointestinal bleeding in this 
group.
From a clinical perspective this thesis makes some important contributions towards
improving patient care. Firstly, knowledge of the patterns of disease and likely
complications in different age-groups is helpful to facilitate development of suitable
management guidelines that are relevant to the age-groups at risk. For example,
considerable efforts have been put into the development of fluid management
guidelines for children while as yet there is little advice on how to manage adults, at
least in part because until recently fluid resuscitation was not viewed as a clinical
problem relevant to this patient group. In general adults need smaller volumes of
intravenous fluid per kilogram body weight compared to children, and it is not
appropriate to simply extrapolate from the current paediatric guidelines. Thus
although DSS occurs less frequently in adults than children, as the overall number of
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adult cases is increasing globally, more attention will need to be addressed to 
developing appropriate guidelines. Secondly, in the small number of adults with 
severe shock or bleeding, liver failure etc. there may be a requirement for invasive 
procedures such as insertion of central lines or chest drains. Extra care must be taken 
with these patients since they usually also have profound thrombocytopenia and a 
serious coagulopathy; only very experienced staff in specialized centres should 
perform these procedures and serious consideration should be given as to whether the 
procedure is really necessary. Use of prophylactic platelet transfusions, fresh frozen 
plasma, cryoprecipitate etc should all be considered and an effective blood transfusion 
service is essential for management of severe dengue cases. These situations are very 
rare however, and it is important to remember that in the great majority of adults with 
dengue, even those with profound thrombocytopenia and significant coagulopathy, 
serious bleeding does not occur and watchful waiting is all that is required since the 
abnormalities are transient and generally improve spontaneously. The question of 
intervention with platelet transfusions is discussed below.
6.2 Limitations of the thesis
The clinical studies described were all hospital based and thus care must be taken 
when extrapolating the findings to a population level. Although we do not think we 
missed many patients from our hospital catchment area, it is possible that some were 
seen at other local centres. Secondly although patients were seen daily, for the 
analysis bleeding severity was described in terms of an overall score for each patient,
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including events that occurred prior to hospitalisation. Thus we were not able to 
examine relationships between development/deterioration of bleeding and concurrent 
specific haemostatic abnormalities. Also we did not have comparable data on the 
coagulopathy from the paediatric patient cohort -  the patterns observed in the adult 
cohort were very similar to our previous findings in children, but we were not able to 
make direct comparisons to assess age-related differences in the magnitude of the 
abnormalities detected. Finally for this work we concentrated on investigating 
potential mechanisms responsible for the prolonged APTT in dengue patients. 
Understanding the mechanisms responsible for the other typical haemostatic 
derangements, such as thrombocytopenia and low plasma fibrinogen levels, is equally 
important and we are currently developing these areas of research.
6.3 Further studies
To investigate further the observed APTT changes we have developed a collaboration 
with Professor Ram Sasisekharan’s group at MIT, aiming to extract and characterize 
the HS present in dengue plasma using a variety of techniques. In particular we wish 
to establish whether these molecules contain binding sites for antithrombin and 
whether the surface glycocalyx layer is the likely origin of the HS molecules. In this 
way we hope to answer not only the question of whether the HS molecules contribute 
to the coagulopathy by functioning as anticoagulants but also to give more insight into 
the pathogenesis of vascular leakage. Secondly up to now no prognostic markers for 
the likely development of vascular leakage have been identified. However plasma HS
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levels proved to be easy to measure by ELISA, and we have shown good correlations 
with clinical disease severity during the critical and convalescent periods. A study to 
determine whether early increases in HS levels predict the subsequent development of 
severe vascular leakage or DSS would be very useful, but would likely require very 
large numbers of participants to be enrolled, given the overall rate of progression to 
DSS in our setting is around 5%. Also at present, with the withdrawal of Seikagaku’s 
ELISA kit after the Japanese tsunami, a simple and reliable method to measure HS is 
no longer available. We are working with the MIT group to try to develop a new 
ELISA, using the same monoclonal antibodies as are in the Seikagaku kit, and will 
then consider further studies to look at HS levels as a prognostic factor.
As discussed in Chapter 4, a detailed study measuring serial plasma concentrations
and activities of coagulation factors of the “intrinsic” and “extrinsic” pathways, as
well as urinary excretion of these factors throughout the course of illness, could be
helpful in investigating the mechanisms responsible for the prolonged APTT with a
relatively normal PT. An alternative method to look at possible leakage of coagulation
factors would be to examine the microvasculature directly, through examination of
skin biopsies. Therefore we have established a study to obtain small skin biopsies
(punch or shave) from patients within 24 hours of admission with DSS, provided the
subject is clinically stable. Immunohistochemistry and EM studies of these biopsies,
together with similar biopsies from healthy volunteers, are ongoing but the
preliminary findings do support the theory that coagulation proteins leak to the
interstitial space. Fibrinogen is of particular interest as plasma levels can be extremely
155
Chapter 6 - Conclusion
low in children with DSS, but without good evidence for consumption/DIC. Although 
it is a relatively large molecule (molecular weight = 340,000 Daltons), animal studies 
indicate that fibrinogen passes though the endothelial surface glycocalyx at a similar 
rate to albumin, possibly related to its elongated shape [128]. We are currently 
carrying out a specific study measuring serial plasma fibrinogen levels and urine 
fibrinogen to creatinine ratios, together with immunohistochemistry for fibrin and 
fibrinogen on skin biopsy samples from the same patients obtained at the peak of 
plasma leakage. This may help to confirm whether leakage of fibrinogen is the 
primary mechanism for the low plasma fibrinogen levels observed.
Finally dengue patients, particularly adults, often present to medical attention during 
the critical period with significant thrombocytopenia but without clinical evidence of 
bleeding. The management strategy for such patients is not well established; in some 
countries prophylactic platelet transfusion has become established as the standard of 
care although there is no evidence that such transfusions influence outcome [110]. At 
HTD, we very rarely transfuse platelets to these patients, and in almost all cases the 
platelet count rises promptly during the second week of illness without development 
of any bleeding, other than minor skin bleeding at venepuncture sites. Before use of 
platelet transfusions for patients with dengue becomes widespread across endemic 
countries it is important that formal research studies are conducted to look at potential 
benefits, associated clinical risks and the cost implications of such transfusions.
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